<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id>
<journal-id journal-id-type="publisher-id">CNS</journal-id>
<journal-title-group>
<journal-title>CNS Neuroscience &amp; Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1755-5930</issn>
<issn pub-type="epub">1755-5949</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31197948</article-id>
<article-id pub-id-type="pmc">6566181</article-id>
<article-id pub-id-type="doi">10.1111/cns.13156</article-id>
<article-id pub-id-type="publisher-id">CNS13156</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>KCTD</italic>: A new gene family involved in neurodevelopmental and neuropsychiatric disorders</article-title>
<alt-title alt-title-type="left-running-head">TENG et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="cns13156-cr-0001">
<name>
<surname>Teng</surname>
<given-names>Xinchen</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2427-9371</contrib-id>
<xref ref-type="aff" rid="cns13156-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns13156-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns13156-cr-0002">
<name>
<surname>Aouacheria</surname>
<given-names>Abdel</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6712-9595</contrib-id>
<xref ref-type="aff" rid="cns13156-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns13156-cr-0003">
<name>
<surname>Lionnard</surname>
<given-names>Loïc</given-names>
</name>
<xref ref-type="aff" rid="cns13156-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns13156-cr-0004">
<name>
<surname>Metz</surname>
<given-names>Kyle A.</given-names>
</name>
<xref ref-type="aff" rid="cns13156-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="cns13156-curr-0001">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns13156-cr-0005">
<name>
<surname>Soane</surname>
<given-names>Lucian</given-names>
</name>
<xref ref-type="aff" rid="cns13156-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns13156-cr-0006">
<name>
<surname>Kamiya</surname>
<given-names>Atsushi</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4274-5567</contrib-id>
<xref ref-type="aff" rid="cns13156-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cns13156-cr-0007">
<name>
<surname>Hardwick</surname>
<given-names>J. Marie</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4847-2045</contrib-id>
<address>
<email>hardwick@jhu.edu</email>
</address>
<xref ref-type="aff" rid="cns13156-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cns13156-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences</named-content>
<institution>Soochow University</institution>
<named-content content-type="city">Suzhou</named-content>
<country country="CN">China</country>
</aff>
<aff id="cns13156-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">W. Harry Feinstone Department of Molecular Microbiology and Immunology</named-content>
<institution>Johns Hopkins University Bloomberg School of Public Health</institution>
<named-content content-type="city">Baltimore</named-content>
<named-content content-type="country-part">Maryland</named-content>
</aff>
<aff id="cns13156-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">ISEM, Institut des Sciences de l'Evolution de Montpellier, CNRS, EPHE, IRD</named-content>
<institution>Université de Montpellier</institution>
<named-content content-type="city">Montpellier</named-content>
<country country="FR">France</country>
</aff>
<aff id="cns13156-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry and Behavioral Sciences</named-content>
<institution>Johns Hopkins School of Medicine</institution>
<named-content content-type="city">Baltimore</named-content>
<named-content content-type="country-part">Maryland</named-content>
</aff>
<aff id="cns13156-curr-0001"><label><sup>5</sup></label>Present address:
<named-content content-type="organisation-division">Feinberg School of Medicine</named-content>
<institution>Northwestern University</institution>
<named-content content-type="city">Chicago</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
J. Marie Hardwick, Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.<break></break>
Email: <email>hardwick@jhu.edu</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>7</month>
<year>2019</year>
</pub-date>
<volume>25</volume>
<issue>7</issue>
<issue-id pub-id-type="doi">10.1111/cns.2019.25.issue-7</issue-id>
<issue-title>Special Issue on Mitochondrion: function and diseases in CNS</issue-title>
<fpage>887</fpage>
<lpage>902</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>CNS Neuroscience &amp; Therapeutics</italic> Published by John Wiley &amp; Sons Ltd.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CNS-25-887.pdf" xlink:type="simple"></self-uri>
<abstract id="cns13156-abs-0001">
<title>Abstract</title>
<p>The underlying molecular basis for neurodevelopmental or neuropsychiatric disorders is not known. In contrast, mechanistic understanding of other brain disorders including neurodegeneration has advanced considerably. Yet, these do not approach the knowledge accrued for many cancers with precision therapeutics acting on well‐characterized targets. Although the identification of genes responsible for neurodevelopmental and neuropsychiatric disorders remains a major obstacle, the few causally associated genes are ripe for discovery by focusing efforts to dissect their mechanisms. Here, we make a case for delving into mechanisms of the poorly characterized human <italic>KCTD</italic> gene family. Varying levels of evidence support their roles in neurocognitive disorders (<italic>KCTD3</italic>), neurodevelopmental disease (<italic>KCTD7</italic>), bipolar disorder (<italic>KCTD12</italic>), autism and schizophrenia (<italic>KCTD13</italic>), movement disorders (<italic>KCTD17</italic>), cancer (<italic>KCTD11</italic>), and obesity (<italic>KCTD15</italic>). Collective knowledge about these genes adds enhanced value, and critical insights into potential disease mechanisms have come from unexpected sources. Translation of basic research on the KCTD‐related yeast protein Whi2 has revealed roles in nutrient signaling to mTORC1 (KCTD11) and an autophagy‐lysosome pathway affecting mitochondria (KCTD7). Recent biochemical and structure‐based studies (KCTD12, KCTD13, KCTD16) reveal mechanisms of regulating membrane channel activities through modulation of distinct GTPases. We explore how these seemingly varied functions may be disease related.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cns13156-kwd-0001">KCTD11</kwd>
<kwd id="cns13156-kwd-0002">KCTD13</kwd>
<kwd id="cns13156-kwd-0003">KCTD7</kwd>
<kwd id="cns13156-kwd-0004">Neurodegeneration</kwd>
<kwd id="cns13156-kwd-0005">Neurodevelopmental disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Jiangsu Key Laboratory of Neuropsychiatric Diseases</funding-source>
<award-id>BM2013003</award-id>
</award-group>
<award-group>
<funding-source>National Institutes of Heath</funding-source>
<award-id>P50MH094268</award-id>
<award-id>R01DA041208</award-id>
<award-id>R01GM077875</award-id>
<award-id>R01NS083373</award-id>
</award-group>
<award-group>
<funding-source>Wendy Klag Center for Autism and Developmental Disabilities</funding-source>
</award-group>
<award-group>
<funding-source>Fondation ARC pour la Recherche sur le Cancer</funding-source>
</award-group>
<award-group>
<funding-source>Ligue Contre le Cancer Comité du Gard</funding-source>
</award-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>31401197</award-id>
<award-id>BM2013003</award-id>
</award-group>
<award-group>
<funding-source>Fondation ARC</funding-source>
</award-group>
<award-group>
<funding-source>Ligue Contre le Cancer</funding-source>
</award-group>
<award-group>
<funding-source>National Institutes of Health</funding-source>
<award-id>P50MH094268</award-id>
<award-id>R01DA041208</award-id>
<award-id>R01NS083373</award-id>
<award-id>R01GM077875</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<page-count count="16"></page-count>
<word-count count="12020"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cns13156</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>July 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.4 mode:remove_FC converted:14.06.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="cns13156-cit-1001" publication-type="journal">
<string-name>
<surname>Teng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Aouacheria</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lionnard</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>
<italic>KCTD</italic>: A new gene family involved in neurodevelopmental and neuropsychiatric disorders</article-title>. <source xml:lang="en"/>CNS Neurosci Ther. <year>2019</year>;<volume>25</volume>:<fpage>887</fpage>–<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1111/cns.13156</pub-id>
</mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="cns13156-sec-0001">
<label>1</label>
<title>INTRODUCTION</title>
<p>Understanding the molecular basis of neurodevelopmental and neuropsychiatric disorders has many obstacles inherent to disease complexities and the lack of tractable model systems analogous to cancer biology. However, remarkable advancements in genomics have identified many potential candidate genes, some with additional compelling evidence for causal involvement in developmental and psychiatric brain disorders. Most gene candidates are relatively uncharacterized compared to the decades of accumulated knowledge for some tumor suppressors and oncogenes. New exploratory research is needed to decipher the mechanistic details and organismal functions of those genes contributing to neurodevelopmental and neuropsychiatric disorders.</p>
<p>A prime candidate for focused attention is the understudied 25‐member <italic>KCTD</italic> gene family. Several human <italic>KCTD</italic> genes have emerged in association with neurodevelopmental, neuropsychiatric, and neurodegenerative disorders. Additional <italic>KCTD</italic> family members are associated with several types of cancer and other disorders, providing additional perspectives. While mutations in individual <italic>KCTD</italic> genes are found in a limited number of patients, collectively they provide a compelling basis to justify interrogation of their molecular and cellular functions to understand disease mechanisms. The biochemical and biological functions of KCTD proteins have not been deciphered, but progress is underway (Table <xref ref-type="table" rid="cns13156-tbl-0001">1</xref>). Some <italic>KCTD</italic> disease associations will need further validation, and likely many others are not yet identified. Deciphering the shared and distinct functions of multiple KCTD family members will provide a wealth of knowledge toward understanding neurodevelopmental, neuropsychiatric, and degenerative processes that were previously impermeable to interrogation.</p>
<table-wrap id="cns13156-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Disease associations, protein functions and structure determinations for all human KCTD family proteins and yeast Whi2.</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Clade Figure <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">BTB structure</th>
<th align="left" colspan="1" rowspan="1" valign="top">Binding partners</th>
<th align="left" colspan="1" rowspan="1" valign="top">Biological functions</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="4">E</td>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD17</bold>
</td>
<td align="left" colspan="1" rowspan="1">closed pentamer (X‐ray<xref ref-type="ref" rid="cns13156-bib-0007">7</xref>)</td>
<td align="left" colspan="1" rowspan="1">Cul3 <xref ref-type="ref" rid="cns13156-bib-0002">2</xref>, <xref ref-type="ref" rid="cns13156-bib-0032">32</xref> (5:5 SAXS <xref ref-type="ref" rid="cns13156-bib-0005">5</xref>, <xref ref-type="ref" rid="cns13156-bib-0007">7</xref>)</td>
<td align="left" colspan="1" rowspan="1">Promotes ciliogenesis by degrading trichoplein<xref ref-type="ref" rid="cns13156-bib-0032">32</xref>, <xref ref-type="ref" rid="cns13156-bib-0106">106</xref>
</td>
<td align="left" colspan="1" rowspan="1">Gen vars associated with dystonia<xref ref-type="ref" rid="cns13156-bib-0079">79</xref>, <xref ref-type="ref" rid="cns13156-bib-0083">83</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KCTD5</td>
<td align="left" colspan="1" rowspan="1">closed pentamer (EM,<xref ref-type="ref" rid="cns13156-bib-0107">107</xref> X‐ray<xref ref-type="ref" rid="cns13156-bib-0003">3</xref>)</td>
<td align="left" colspan="1" rowspan="1">Cul3<xref ref-type="ref" rid="cns13156-bib-0002">2</xref> (5:5 ITC<xref ref-type="ref" rid="cns13156-bib-0037">37</xref>)</td>
<td align="left" colspan="1" rowspan="1">Inhibits GPCR signal, degrades Gβγ<xref ref-type="ref" rid="cns13156-bib-0018">18</xref>; monoubiquitination of ΔNp63α<xref ref-type="ref" rid="cns13156-bib-0108">108</xref>
</td>
<td align="left" colspan="1" rowspan="1">Involved in sleep regulation<xref ref-type="ref" rid="cns13156-bib-0086">86</xref>, <xref ref-type="ref" rid="cns13156-bib-0109">109</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KCTD2</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Clu3<xref ref-type="ref" rid="cns13156-bib-0029">29</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Degrades c‐Myc<xref ref-type="ref" rid="cns13156-bib-0029">29</xref>
<break></break>
Regulates sleep<xref ref-type="ref" rid="cns13156-bib-0086">86</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Low in patient‐derived glioma stem cells <xref ref-type="ref" rid="cns13156-bib-0029">29</xref>
<break></break>
Gen vars assoc. with Alzheimer's risk (GWAS)<xref ref-type="ref" rid="cns13156-bib-0110">110</xref>, <xref ref-type="ref" rid="cns13156-bib-0111">111</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KCTD9</td>
<td align="left" colspan="1" rowspan="1">Closed pentamer (X‐ray<xref ref-type="ref" rid="cns13156-bib-0002">2</xref>)</td>
<td align="left" colspan="1" rowspan="1">Cul3 (5:5 cryo‐EM<xref ref-type="ref" rid="cns13156-bib-0002">2</xref>)</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">D</td>
<td align="left" colspan="1" rowspan="1">SHKBP1</td>
<td align="left" colspan="1" rowspan="1">monomer (X‐ray<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>)</td>
<td align="left" colspan="1" rowspan="1">
Cul3 (5:5 SAXS<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>)<break></break>
CIN85<xref ref-type="ref" rid="cns13156-bib-0112">112</xref>
<break></break>
SETA<xref ref-type="ref" rid="cns13156-bib-0113">113</xref>
</td>
<td align="left" colspan="1" rowspan="1">Promotes EGFR pathway by disrupting c‐Cbl‐CIN85 complex<xref ref-type="ref" rid="cns13156-bib-0112">112</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Mutated in cervical cancer<xref ref-type="ref" rid="cns13156-bib-0114">114</xref>
<break></break>
Mutated in leukemia<xref ref-type="ref" rid="cns13156-bib-0115">115</xref>
<break></break>
Biomarker in small intestinal neuroendocrine tumors<xref ref-type="ref" rid="cns13156-bib-0116">116</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD3</bold>
</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">HCN3<xref ref-type="ref" rid="cns13156-bib-0091">91</xref>
</td>
<td align="left" colspan="1" rowspan="1">Up‐regulation of HCN3<xref ref-type="ref" rid="cns13156-bib-0091">91</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Biallelic mutations in epileptic encephalopathy<xref ref-type="ref" rid="cns13156-bib-0090">90</xref>
<break></break>
Gen vars in intellectual disability/ seizures (WES)<xref ref-type="ref" rid="cns13156-bib-0088">88</xref>, <xref ref-type="ref" rid="cns13156-bib-0089">89</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">C</td>
<td align="left" colspan="1" rowspan="1">KCTD10</td>
<td align="left" colspan="1" rowspan="1">tetramer (X‐ray<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>)</td>
<td align="left" colspan="1" rowspan="1">
Cul3<xref ref-type="ref" rid="cns13156-bib-0031">31</xref>, <xref ref-type="ref" rid="cns13156-bib-0035">35</xref>, <xref ref-type="ref" rid="cns13156-bib-0117">117</xref>
<break></break>
PCNA<xref ref-type="ref" rid="cns13156-bib-0006">6</xref>
<break></break>
TNFAIP1<xref ref-type="ref" rid="cns13156-bib-0118">118</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Degrades RhoB<xref ref-type="ref" rid="cns13156-bib-0031">31</xref>, <xref ref-type="ref" rid="cns13156-bib-0035">35</xref>
<break></break>
Promotes cilium, degrades CEP97<xref ref-type="ref" rid="cns13156-bib-0117">117</xref>
<break></break>
DNA synthesis, cell proliferation<xref ref-type="ref" rid="cns13156-bib-0006">6</xref>
<break></break>
Inhibits NF‐κB and AP‐1<xref ref-type="ref" rid="cns13156-bib-0118">118</xref>
</td>
<td align="left" colspan="1" rowspan="1">Tumor suppressor in gastrointestinal stromal tumor<xref ref-type="ref" rid="cns13156-bib-0119">119</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNFAIP1</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">
Cul3<xref ref-type="ref" rid="cns13156-bib-0033">33</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref>
<break></break>
RhoB<xref ref-type="ref" rid="cns13156-bib-0120">120</xref>
<break></break>
PCNA<xref ref-type="ref" rid="cns13156-bib-0008">8</xref>
<break></break>
KCTD10<xref ref-type="ref" rid="cns13156-bib-0118">118</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Degrades RhoA<xref ref-type="ref" rid="cns13156-bib-0033">33</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref>
<break></break>
Regulates apoptosis<xref ref-type="ref" rid="cns13156-bib-0120">120</xref>
<break></break>
Inhibits NF‐κB and AP‐1 <xref ref-type="ref" rid="cns13156-bib-0118">118</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Aa a tumor suppressor in nonsmall cell lung cancer<xref ref-type="ref" rid="cns13156-bib-0121">121</xref>
<break></break>
Poor prognosis if overexpressed in breast cancer<xref ref-type="ref" rid="cns13156-bib-0122">122</xref>
<break></break>
Overexpressed in osteosarcoma<xref ref-type="ref" rid="cns13156-bib-0123">123</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD13</bold>
</td>
<td align="left" colspan="1" rowspan="1">
tetra‐ (X‐ray<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>)<break></break>
pentamer (EM<xref ref-type="ref" rid="cns13156-bib-0107">107</xref>)
</td>
<td align="left" colspan="1" rowspan="1">
Cul3<xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0033">33</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref> (5:5 SAXS<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>) SAXS<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>
<break></break>
PCNA<xref ref-type="ref" rid="cns13156-bib-0007">7</xref>
</td>
<td align="left" colspan="1" rowspan="1">Degrades RhoA<xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0033">33</xref>, <xref ref-type="ref" rid="cns13156-bib-0034">34</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Copy‐number var associated with autism<xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0052">52</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref>
<break></break>
Mutations associated with schizophrenia<xref ref-type="ref" rid="cns13156-bib-0124">124</xref>
<break></break>
Overexpression: microcephaly in zebrafish, mouse<xref ref-type="ref" rid="cns13156-bib-0034">34</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">H</td>
<td align="left" colspan="1" rowspan="1">KCTD14</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD7</bold>
</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Cul3<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>, <xref ref-type="ref" rid="cns13156-bib-0036">36</xref>
</td>
<td align="left" colspan="1" rowspan="1">Regulates neuronal autophagy,<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Gln transport SAT2,<xref ref-type="ref" rid="cns13156-bib-0023">23</xref> K<sup>+</sup> conductance<xref ref-type="ref" rid="cns13156-bib-0020">20</xref>
</td>
<td align="left" colspan="1" rowspan="1">Bi‐allelic mutations cause severe early onset progressive disorder with epilepsy<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>, <xref ref-type="ref" rid="cns13156-bib-0038">38</xref>, <xref ref-type="ref" rid="cns13156-bib-0039">39</xref>, <xref ref-type="ref" rid="cns13156-bib-0040">40</xref>, <xref ref-type="ref" rid="cns13156-bib-0041">41</xref>, <xref ref-type="ref" rid="cns13156-bib-0125">125</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">B</td>
<td align="left" colspan="1" rowspan="1">KCTD6</td>
<td align="left" colspan="1" rowspan="1">pentamer (EM<xref ref-type="ref" rid="cns13156-bib-0107">107</xref>)</td>
<td align="left" colspan="1" rowspan="1">Cul3<xref ref-type="ref" rid="cns13156-bib-0002">2</xref> (4:4 gel filtration<xref ref-type="ref" rid="cns13156-bib-0016">16</xref>)</td>
<td align="left" colspan="1" rowspan="1">
Suppresses Hh pathway by degrading HDAC<xref ref-type="ref" rid="cns13156-bib-0030">30</xref> and USP21<xref ref-type="ref" rid="cns13156-bib-0126">126</xref>
<break></break>
Degrades small ankyrin‐1<xref ref-type="ref" rid="cns13156-bib-0127">127</xref>
</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KCTD21</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Cul3<xref ref-type="ref" rid="cns13156-bib-0030">30</xref>
</td>
<td align="left" colspan="1" rowspan="1">Inhibits Hh by degrading HDAC<xref ref-type="ref" rid="cns13156-bib-0030">30</xref>
</td>
<td align="left" colspan="1" rowspan="1">Gen vars associated with autism (WES)<xref ref-type="ref" rid="cns13156-bib-0128">128</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD11</bold>
</td>
<td align="left" colspan="1" rowspan="1">
tetramer (gel filtration),<xref ref-type="ref" rid="cns13156-bib-0096">96</xref>
<break></break>
pentamer (EM<xref ref-type="ref" rid="cns13156-bib-0107">107</xref>)
</td>
<td align="left" colspan="1" rowspan="1">Cul3 (4:4 gel filtration<xref ref-type="ref" rid="cns13156-bib-0016">16</xref>, <xref ref-type="ref" rid="cns13156-bib-0096">96</xref>)</td>
<td align="left" colspan="1" rowspan="1">
Inhibits mTORC1 activity<xref ref-type="ref" rid="cns13156-bib-0014">14</xref>
<break></break>
Inhibits Hh pathway by degrading HDAC<xref ref-type="ref" rid="cns13156-bib-0012">12</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Deletion/ reduced expression in medulloblastoma<xref ref-type="ref" rid="cns13156-bib-0094">94</xref>
<break></break>
Loss of heterozygosity in prostate adenocarcinoma<xref ref-type="ref" rid="cns13156-bib-0129">129</xref>
<break></break>
Reduced expression in hepatocellular carcinoma<xref ref-type="ref" rid="cns13156-bib-0130">130</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other</td>
<td align="left" colspan="1" rowspan="1">KCTD4</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">A</td>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD15</bold>
</td>
<td align="left" colspan="1" rowspan="1">pentamer (EM<xref ref-type="ref" rid="cns13156-bib-0107">107</xref>)</td>
<td align="left" colspan="1" rowspan="1">AP‐2α<xref ref-type="ref" rid="cns13156-bib-0010">10</xref>
</td>
<td align="left" colspan="1" rowspan="1">Inhibits neural crest formation by inhibiting AP‐2α<xref ref-type="ref" rid="cns13156-bib-0010">10</xref> &amp; Wnt pathway<xref ref-type="ref" rid="cns13156-bib-0099">99</xref>
</td>
<td align="left" colspan="1" rowspan="1">Genetic variants associated with obesity<xref ref-type="ref" rid="cns13156-bib-0097">97</xref>, <xref ref-type="ref" rid="cns13156-bib-0098">98</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KCTD1</td>
<td align="left" colspan="1" rowspan="1">closed/open pentamer (EM,<xref ref-type="ref" rid="cns13156-bib-0107">107</xref> X‐ray<xref ref-type="ref" rid="cns13156-bib-0002">2</xref>)</td>
<td align="left" colspan="1" rowspan="1">AP‐2α transcription factor<xref ref-type="ref" rid="cns13156-bib-0009">9</xref>
</td>
<td align="left" colspan="1" rowspan="1">Inhibits transcription factor AP‐2α<xref ref-type="ref" rid="cns13156-bib-0009">9</xref> and Wnt signaling by degrading β‐catenin<xref ref-type="ref" rid="cns13156-bib-0131">131</xref>
</td>
<td align="left" colspan="1" rowspan="1">
I27N mutation caused kidney dysfunction in mice<xref ref-type="ref" rid="cns13156-bib-0132">132</xref>
<break></break>
Missense mutations associated with scalp‐ear‐nipple syndrome<xref ref-type="ref" rid="cns13156-bib-0133">133</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other</td>
<td align="left" colspan="1" rowspan="1">KCTD19</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">F</td>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD12</bold>
</td>
<td align="left" colspan="1" rowspan="1">pentamer (EM<xref ref-type="ref" rid="cns13156-bib-0107">107</xref>; X‐ray<xref ref-type="ref" rid="cns13156-bib-0019">19</xref>)</td>
<td align="left" colspan="1" rowspan="1">
GABA<sub>B2</sub>
<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>
<break></break>
Gβγ<xref ref-type="ref" rid="cns13156-bib-0019">19</xref>
<break></break>
CDC25B<xref ref-type="ref" rid="cns13156-bib-0134">134</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Regulates GABA<sub>B2 </sub>receptor signaling<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>, <xref ref-type="ref" rid="cns13156-bib-0019">19</xref>, <xref ref-type="ref" rid="cns13156-bib-0135">135</xref>, <xref ref-type="ref" rid="cns13156-bib-0136">136</xref>
<break></break>
Suppresses Wnt‐Notch pathway<xref ref-type="ref" rid="cns13156-bib-0137">137</xref>
<break></break>
Promotes G2/M transition<xref ref-type="ref" rid="cns13156-bib-0134">134</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Emotionality, neuronal excitability (mice)<xref ref-type="ref" rid="cns13156-bib-0065">65</xref>
<break></break>
KCTD12 increases 5‐y survival in GI stromal tumor<xref ref-type="ref" rid="cns13156-bib-0138">138</xref>
<break></break>
Increased KCTD12 in cervical and lung cancers<xref ref-type="ref" rid="cns13156-bib-0134">134</xref>
<break></break>
Bipolar disorder (GWAS)<xref ref-type="ref" rid="cns13156-bib-0062">62</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>KCTD16</bold>
</td>
<td align="left" colspan="1" rowspan="1">open pentamer (X‐ray<xref ref-type="ref" rid="cns13156-bib-0005">5</xref>, <xref ref-type="ref" rid="cns13156-bib-0019">19</xref>)</td>
<td align="left" colspan="1" rowspan="1">
GABA<sub>B2</sub>
<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>
<break></break>
Gβγ<xref ref-type="ref" rid="cns13156-bib-0019">19</xref>
</td>
<td align="left" colspan="1" rowspan="1">Regulates GABA<sub>B2</sub> receptor signaling<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>, <xref ref-type="ref" rid="cns13156-bib-0019">19</xref>, <xref ref-type="ref" rid="cns13156-bib-0135">135</xref>, <xref ref-type="ref" rid="cns13156-bib-0136">136</xref>
</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KCTD8</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">GABA<sub>B2</sub>
<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>
</td>
<td align="left" colspan="1" rowspan="1">Regulates GABA<sub>B2 </sub>signaling<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>, <xref ref-type="ref" rid="cns13156-bib-0135">135</xref>, <xref ref-type="ref" rid="cns13156-bib-0136">136</xref>
</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other</td>
<td align="left" colspan="1" rowspan="1">KCNRG</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Kv channel<xref ref-type="ref" rid="cns13156-bib-0139">139</xref>, <xref ref-type="ref" rid="cns13156-bib-0140">140</xref>
</td>
<td align="left" colspan="1" rowspan="1">Suppresses K + channel activity<xref ref-type="ref" rid="cns13156-bib-0139">139</xref>
</td>
<td align="left" colspan="1" rowspan="1">Deleted in B‐cell chronic lymphocytic leukemia,<xref ref-type="ref" rid="cns13156-bib-0140">140</xref>, <xref ref-type="ref" rid="cns13156-bib-0141">141</xref>, <xref ref-type="ref" rid="cns13156-bib-0142">142</xref> prostate cancer<xref ref-type="ref" rid="cns13156-bib-0140">140</xref> and multiple myeloma<xref ref-type="ref" rid="cns13156-bib-0142">142</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other</td>
<td align="left" colspan="1" rowspan="1">KCTD18</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">
Duplication of 2q33 in one patient with epilepsy, devel. delay, autistic behavior<xref ref-type="ref" rid="cns13156-bib-0143">143</xref>
<break></break>
Haplotype associated with restless legs syndrome<xref ref-type="ref" rid="cns13156-bib-0144">144</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">G</td>
<td align="left" colspan="1" rowspan="1">KCTD20</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Activates Akt<xref ref-type="ref" rid="cns13156-bib-0145">145</xref>, <xref ref-type="ref" rid="cns13156-bib-0146">146</xref>
</td>
<td align="left" colspan="1" rowspan="1">Gen var associated with insulin resistance (GWAS)<xref ref-type="ref" rid="cns13156-bib-0147">147</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BTBD10</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Akt1‐3<xref ref-type="ref" rid="cns13156-bib-0148">148</xref>
</td>
<td align="left" colspan="1" rowspan="1">Inhibits apoptosis, activates Akt<xref ref-type="ref" rid="cns13156-bib-0149">149</xref>, <xref ref-type="ref" rid="cns13156-bib-0150">150</xref>
</td>
<td align="left" colspan="1" rowspan="1">Sporadic amyotrophic lateral sclerosis<xref ref-type="ref" rid="cns13156-bib-0151">151</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Sc</italic>
</td>
<td align="left" colspan="1" rowspan="1">
<bold>Whi2</bold>
</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Psr1<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>
</td>
<td align="left" colspan="1" rowspan="1">Suppresses TORC1, promotes autophagy induction<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>
</td>
<td align="left" colspan="1" rowspan="1">Plant pathogen CoWhi2 has suggested role in pathogenesis during infection<xref ref-type="ref" rid="cns13156-bib-0152">152</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<title>Notes</title>
<fn id="cns13156-note-0001">
<p>5:5/4:4, pentameric or tetrameric symmetry when bound to binding partners; X‐ray/EM/gel‐filtration/SAXS‐small angle X‐ray scattering SAXS, structure determination methods.</p>
</fn>
<fn id="cns13156-note-0002">
<p>Abbreviations: Gen vars, genetic variants associated with disease; ND, not determined; GWAS, genome‐wide association study; <italic>Sc, Saccharomyces cerevisiae</italic> (baker's yeast); WES, whole exome sequencing.</p>
</fn>
<fn id="cns13156-note-0003">
<p>Bold type: KCTD proteins discussed in separate sections of this article.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Human KCTD family proteins (KCTD1‐21, TNFAIP1, KCNRG, SHKBP1, and BTBD10) can localize in the cytoplasm or the nucleus, and range in size from 26‐kDa KCTD5 (234 amino acids) to 105‐kDa KCTD19 (926 amino acids). Mice encode an additional KCTD protein, Kctd12b (chromosome X), which is highly similar to mouse Kctd12 (chromosome 14). The distinguishing feature of KCTD proteins is a single N‐terminal BTB/POZ (bric‐a‐brac, tramtrak, and broad complex/poxvirus zinc finger) domain, the exception being KCTD19 with three separate BTBs that may reflect tandem gene amplification (Figure <xref ref-type="fig" rid="cns13156-fig-0001">1</xref>).<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> BLAST searches readily reveal that the BTB domains of KCTD family proteins are most similar in amino acid sequence to the T1/BTB domains that mediate tetramerization of voltage‐gated potassium channel subunits to form functional channels.<xref ref-type="ref" rid="cns13156-bib-0001">1</xref>, <xref ref-type="ref" rid="cns13156-bib-0002">2</xref> This sequence similarity to Kv channels explains how KCTDs acquired their official name (potassium channel tetramerization domain). However, KCTD family proteins lack predicted transmembrane domains.<xref ref-type="ref" rid="cns13156-bib-0003">3</xref>
</p>
<fig fig-type="Figure" id="cns13156-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>The diverse human KCTD protein family and yeast Whi2. Line diagrams of the 25 human KCTD family proteins and <italic>Saccharomyces cerevisiae</italic> Whi2 are drawn to scale, grouped in color‐coded clades (A‐H), ordered as in Figure <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>, and aligned with respect to their BTB domain (solid rectangles). Additional protein domains with known or inferred structures (KHA, YjbI, WD40, H1) and similarity region H2 are also represented. KCTD11L starts at an AUU start codon adding 39 N‐terminal residues (hashed box) before the first in‐frame AUG translate start. Gray line diagrams indicate proteins not discussed in detail. Scale bar indicates protein length in amino acid residues</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="CNS-25-887-g001"></graphic>
</fig>
<p>An unusual feature of this gene family is their diversity outside the BTB domain. Except within subgroups of closely related family members, KCTD proteins lack obvious sequence similarity in their highly variable C‐terminal regions.<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> This feature is consistent with their proposed roles as adaptor molecules that use their C‐termini to bind and recruit diverse cellular proteins destined for degradation. In this model, KCTDs are responsible for selecting protein substrates for ubiquitination by cullin‐RING ubiquitin ligases (CRLs) that bind to the BTB domains of KCTD proteins.<xref ref-type="ref" rid="cns13156-bib-0002">2</xref>, <xref ref-type="ref" rid="cns13156-bib-0004">4</xref>, <xref ref-type="ref" rid="cns13156-bib-0005">5</xref> Thus, disrupted proteostasis required for the delicate balance between protein function versus degradation could potentially underlie neurological disorders now associated with the brain‐enriched proteins KCTD3, KCTD7, KCTD13, and KCTD17. This proposed adaptor function for KCTD proteins could potentially underlie the diverse biological processes reported for KCTD proteins, including DNA replication (KCTD10 and TNFAIP1),<xref ref-type="ref" rid="cns13156-bib-0006">6</xref>, <xref ref-type="ref" rid="cns13156-bib-0007">7</xref>, <xref ref-type="ref" rid="cns13156-bib-0008">8</xref> transcription inhibition (KCTD1 and KCTD15),<xref ref-type="ref" rid="cns13156-bib-0009">9</xref>, <xref ref-type="ref" rid="cns13156-bib-0010">10</xref> regulation of Rho GTPases in brain development (KCTD13),<xref ref-type="ref" rid="cns13156-bib-0011">11</xref> suppression of hedgehog signaling (KCTD11),<xref ref-type="ref" rid="cns13156-bib-0012">12</xref> autophagy induction and amino acid signaling to mTORC1 (KCTD11),<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>, <xref ref-type="ref" rid="cns13156-bib-0014">14</xref>, <xref ref-type="ref" rid="cns13156-bib-0015">15</xref> and more (Table <xref ref-type="table" rid="cns13156-tbl-0001">1</xref>). However, other KCTDs appear to lack the ability to bind cullin‐3, implying distinct biochemical mechanisms.<xref ref-type="ref" rid="cns13156-bib-0016">16</xref> For example, several KCTD family proteins (e.g., KCTD12 and KCTD13) may alter neuronal activity and other signaling pathways by regulating diverse types of GTPases <xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0017">17</xref>, <xref ref-type="ref" rid="cns13156-bib-0018">18</xref>, <xref ref-type="ref" rid="cns13156-bib-0019">19</xref>. Here, we convey our current understanding of KCTD protein structure and function and how this may relate to disease mechanisms, focusing on a subset of KCTD family members implicated in disorders originating from the neural crest.</p>
</sec>
<sec id="cns13156-sec-0002">
<label>2</label>
<title>STRUCTURE AND FUNCTION OF KCTD FAMILY PROTEINS</title>
<p>KCTD family members likely represent paralogs that arose by gene duplication from a common ancestral gene followed by divergence, which led to diversification of the current KCTD protein family in the animal kingdom (Figure <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>). Solved structures are available for the N‐terminal BTB domain of several KCTD family proteins primarily revealing pentameric homo‐oligomers. This fivefold symmetry appears to extend through the C‐terminus.<xref ref-type="ref" rid="cns13156-bib-0001">1</xref>, <xref ref-type="ref" rid="cns13156-bib-0002">2</xref>, <xref ref-type="ref" rid="cns13156-bib-0003">3</xref>, <xref ref-type="ref" rid="cns13156-bib-0019">19</xref> The BTB domains of KCTD proteins also mediate other protein‐protein interactions, leading to three main hypotheses for general KCTD mechanisms. The first of these is not favored currently. Reasoning that KCTD‐BTB domains might directly bind to their closest cousins, the T1/BTB (tetramerization) domains of voltage‐gated potassium channels, KCTD proteins could potentially regulate channel assembly or activity. KCTD5 was tested for the ability to bind or affect the functions of Kv1.2, Kv2.1, Kv3.4, and Kv4.2 channels but without success.<xref ref-type="ref" rid="cns13156-bib-0003">3</xref> In a second model, several KCTD family members are reported to indirectly influence channel activity by mechanisms not yet delineated.<xref ref-type="ref" rid="cns13156-bib-0020">20</xref>, <xref ref-type="ref" rid="cns13156-bib-0021">21</xref>, <xref ref-type="ref" rid="cns13156-bib-0022">22</xref>, <xref ref-type="ref" rid="cns13156-bib-0023">23</xref> However, recent advancements in this direction stem for the finding that the BTB domain of a different subset of KCTDs (clade F) interacts with the cytoplasmic tail of membrane‐embedded GABA<sub>B</sub> neurotransmitter receptors allowing the KCTD C‐terminus to transmit a signal that modulates channels in close proximity.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref> The third proposed biochemical mechanisms for KCTD family proteins potentially apply more broadly to the KCTD protein family. The BTB domain of many KCTD family proteins are reported to bind to the cullin‐3 ubiquitin ligase, potentially serving as adaptor molecules to recruit substrates for ubiquitination.<xref ref-type="ref" rid="cns13156-bib-0005">5</xref> However, exactly how the KCTD BTB domain of KCTD proteins would fit onto cullin‐3 is a matter of speculation. Furthermore, little is known about the structure or function of most KCTD C‐termini.</p>
<fig fig-type="Figure" id="cns13156-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Phylogenetic tree of isolated BTB domains from KCTD family homologs. Amino acid sequences of KCTD family proteins from human (<italic>Homo sapiens</italic>, HOMSA), mouse (<italic>Mus musculus,</italic> MUSMU), zebrafish (<italic>Danio rerio</italic>, DANRE), <italic>Drosophila melanogaster</italic> (DROME), <italic>Caenorhabditis elegans</italic> (CAEEL), and three yeast species (<italic>Saccharomyces cerevisiae</italic>, SACCE; <italic>Schizosaccharomyces pombe</italic>, SACPO; <italic>Candida albicans</italic>, CANAL) were collected from UniProt (release 2019_02) or after searches using the DELTA‐BLAST algorithm on the NCBI website. Sequences were aligned using MAFFT (version 7), and a neighbor‐joining (NJ) analysis was performed with 1000 bootstrap replicates. Bootstrap support values above 50 are shown at each node. The tree was rooted using Whi2p from <italic>S pombe</italic>. Yeast sequences were represented as an outgroup (red branches). The arbitrary cluster designations for groups A‐G were assigned to match those reported by Skoblov <italic>et al</italic>.<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> The new H group is deduced from this analysis. Compared to Skoblov <italic>et al</italic>,<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> we found that KCTD9 segregates within group E. Amino acid sequences (Table <xref ref-type="supplementary-material" rid="cns13156-sup-0001">S1</xref>) and alignment results (Table <xref ref-type="supplementary-material" rid="cns13156-sup-0002">S2</xref>) for this analysis are found in Supporting information</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="CNS-25-887-g002"></graphic>
</fig>
<p>KCTD family proteins were previously classified into seven phylogenetic clades based on the amino acid sequences of the BTB regions alone or of the full‐length proteins.<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> Our analysis based on the minimal BTB domains is in agreement with the previous study and suggests the existence of an additional 8th clade that we termed H comprised of KCTD7 and KCTD14 (Figures <xref ref-type="fig" rid="cns13156-fig-0001">1</xref>, <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>). In addition, based on our analysis, we propose to include the BTB of KCTD9 in the E group. Like the related tetrameric T1/BTB domains of voltage‐gated potassium (Kv) channels, the BTB domains of KCTD10 and KCTD13 are capable of forming tetramers. However, the BTB domains of most KCTD proteins form pentamers (KCTD1, −5, −6, −9, −11, −12, −15, −16, −17) based on crystal structures, cryo‐EM, or other methods (Table <xref ref-type="table" rid="cns13156-tbl-0001">1</xref>). The exception is the available structure of SHKBP1‐BTB, which is a monomer.<xref ref-type="ref" rid="cns13156-bib-0005">5</xref> The only available full‐length KCTD protein structure reveals a fivefold symmetry extending through the C‐terminus of KCTD5,<xref ref-type="ref" rid="cns13156-bib-0003">3</xref> consistent with the pentameric structure of the C‐terminal H1 domain of KCTD12.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref>
</p>
<p>BTB domains are found in other well‐known proteins, such as Skip1, an adaptor for cullin‐1 ubiquitin ligase complexes, and KEAP1, which regulates localization of NRF2 in a redox‐responsive manner.<xref ref-type="ref" rid="cns13156-bib-0024">24</xref> The identification of BTB domains from other protein families as cullin‐binding partners by mass spectrometry, including several KCTD family members,<xref ref-type="ref" rid="cns13156-bib-0025">25</xref>, <xref ref-type="ref" rid="cns13156-bib-0026">26</xref>, <xref ref-type="ref" rid="cns13156-bib-0027">27</xref> fuels the search for biological roles for KCTD family proteins as exchangeable adaptors of cullin‐3‐RING E3 ubiquitin ligase complexes (CRLs). In this model, cullin‐3 interacts with the BTB domains of exchangeable adaptor proteins that serve to recruit different protein substrates for ubiquitination by the RBX‐RING protein bound to the C‐terminus of cullin‐3 (Figure <xref ref-type="fig" rid="cns13156-fig-0003">3</xref>).<xref ref-type="ref" rid="cns13156-bib-0027">27</xref>, <xref ref-type="ref" rid="cns13156-bib-0028">28</xref> Thus, KCTD family proteins could function like a multihead screwdriver to recruit different cellular proteins for selective degradation by the proteasome or the lysosome to fine‐tune many cellular processes.<xref ref-type="ref" rid="cns13156-bib-0027">27</xref>
</p>
<fig fig-type="Figure" id="cns13156-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Proposed role for a subset of KCTD family proteins as adaptors for cullin‐3 ubiquitin ligase complexes (CRLs)</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="CNS-25-887-g003"></graphic>
</fig>
<p>Several KCTD family proteins (KCTD2, −5, −6, −10, −11, −13, −17, −21, TNFAIP1) have been reported to interact with cullin‐3 and to mediate ubiquitination and degradation of specific target proteins.<xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0012">12</xref>, <xref ref-type="ref" rid="cns13156-bib-0018">18</xref>, <xref ref-type="ref" rid="cns13156-bib-0029">29</xref>, <xref ref-type="ref" rid="cns13156-bib-0030">30</xref>, <xref ref-type="ref" rid="cns13156-bib-0031">31</xref>, <xref ref-type="ref" rid="cns13156-bib-0032">32</xref>, <xref ref-type="ref" rid="cns13156-bib-0033">33</xref> Cullin‐3 binding to KCTD13, TNFAIP1, and KCTD10 may regulate actin organization and other cell functions by degrading Rho GTPases RhoA or RhoB.<xref ref-type="ref" rid="cns13156-bib-0031">31</xref>, <xref ref-type="ref" rid="cns13156-bib-0033">33</xref>, <xref ref-type="ref" rid="cns13156-bib-0034">34</xref>, <xref ref-type="ref" rid="cns13156-bib-0035">35</xref> KCTD6, KCTD11, and KCTD21 can each assemble with cullin‐3 and are reported to suppress hedgehog signaling by degrading Gli deacetylase HDAC1.<xref ref-type="ref" rid="cns13156-bib-0012">12</xref>, <xref ref-type="ref" rid="cns13156-bib-0030">30</xref> KCTD7, KCTD9, and SHKBP1 are capable of binding cullin‐3, but their substrates have not yet been identified.<xref ref-type="ref" rid="cns13156-bib-0002">2</xref>, <xref ref-type="ref" rid="cns13156-bib-0005">5</xref>, <xref ref-type="ref" rid="cns13156-bib-0036">36</xref> Intriguingly, KCTD5, −9, −13, −17, and SHKBP1 can form 5:5 heterodecameric complexes with cullin‐3 based on biochemical experiments, even though their purified BTB domains may adopt geometries of tetramers or monomers.<xref ref-type="ref" rid="cns13156-bib-0002">2</xref>, <xref ref-type="ref" rid="cns13156-bib-0005">5</xref>, <xref ref-type="ref" rid="cns13156-bib-0037">37</xref> This suggests that cullin‐3 may drive assembly of KCTD protein structures. Validation of this adaptor function by in vitro reconstitution of KCTD‐cullin3‐RBX‐E2 ubiquitination reactions is challenged by the apparent need to identify and include the specific target substrate in these reactions. Detailed biochemistry and structure determinations are also needed to confirm the biological evidence that KCTDs function as cullin‐3 adaptors. Additional binding partners of KCTD proteins also have been identified. KCTD1 and KCTD15 were reported to bind and inhibit the activity of transcription factor AP‐2α.<xref ref-type="ref" rid="cns13156-bib-0009">9</xref>, <xref ref-type="ref" rid="cns13156-bib-0010">10</xref> KCTD10, KCTD13, and TNFAIP1 were reported to regulate DNA replication by interacting with PCNA (proliferating cell nuclear antigen).<xref ref-type="ref" rid="cns13156-bib-0006">6</xref>, <xref ref-type="ref" rid="cns13156-bib-0008">8</xref> Whether these KCTD functions involve cullin‐3 or unrelated mechanisms is not yet established.</p>
</sec>
<sec id="cns13156-sec-0003">
<label>3</label>
<title>
<italic>KCTD</italic> GENES ASSOCIATED WITH NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS</title>
<sec id="cns13156-sec-0004">
<label>3.1</label>
<title>KCTD7 mutations cause a severe neurodevelopmental disorder</title>
<p>Our recent genetic analysis confirms that mutations in <italic>KCTD7</italic> cause a rare early‐onset, autosomal recessive disorder (progressive myoclonic epilepsy/PME3, also called EPM3).<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Over 50 patients with over 40 unique variants in <italic>KCTD7</italic> have been identified to date, though many more likely remain unidentified.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>, <xref ref-type="ref" rid="cns13156-bib-0038">38</xref>, <xref ref-type="ref" rid="cns13156-bib-0039">39</xref>, <xref ref-type="ref" rid="cns13156-bib-0040">40</xref>, <xref ref-type="ref" rid="cns13156-bib-0041">41</xref>, <xref ref-type="ref" rid="cns13156-bib-0042">42</xref>, <xref ref-type="ref" rid="cns13156-bib-0043">43</xref>, <xref ref-type="ref" rid="cns13156-bib-0044">44</xref>, <xref ref-type="ref" rid="cns13156-bib-0045">45</xref> In all cases, patients have homozygous or compound heterozygous mutations (missense, stop‐gain, frameshifts, or large deletions), while all heterozygous family members are unaffected.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Thus far, the highest density of patient variants occurs within the N‐terminal BTB domain. A cluster of mutations also occurs in the last 30 residues and in an ~100‐residue middle region, both of unknown function.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Patients appear to develop normally and achieve early childhood milestones. However, between 10 and 20 months of age these children develop refractory myoclonic seizures, movement disorders, and/or developmental delays.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> This younger age of onset with <italic>KCTD7</italic> mutations (average 16 months) distinguishes these patients from other types of progressive myoclonic epilepsies (PME). All patients subsequently progress, exhibiting severe cognitive decline, motor deficits, and seizures.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Most patients become nonverbal and wheelchair‐bound within 2 years of diagnosis, but the few ambulatory patients now in their teens and early twenties have diagnoses of autism or schizophrenia. This disorder is also designated as neuronal ceroid lipofuscinosis type 14 (CLN14), primarily on the basis of two patients with subcellular inclusions and lysosome storage material.<xref ref-type="ref" rid="cns13156-bib-0036">36</xref>, <xref ref-type="ref" rid="cns13156-bib-0045">45</xref> However, most studies concluded that the subcellular pathologies of KCTD7 patients are distinct from previously described CLN pathologies and other lysosomal storage disorders.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>, <xref ref-type="ref" rid="cns13156-bib-0041">41</xref>
</p>
<p>Persistent difficulties with diagnosing this disorder have been attributed to earlier onset ages than expected for PME disorders, negative biopsy tests for CLN‐related pathologies, negative brain MRI findings (with a few exceptions), and the fact that <italic>KCTD7</italic> was not confirmed as a disease gene until relatively recently. These challenges have been partially overcome by including <italic>KCTD7</italic> on diagnostic sequencing panels for epilepsy. However, at least 25% of patients develop movement disorders (ataxia, tremors, dyskinesia, choreoathetosis, dystonia) or regression of milestones before the onset of seizures, though all eventually develop myoclonic epilepsy. Electrical activity in the brain detected by EEG tests is generally positive, and brain biopsies are predicted to be diagnostic based on the prevalence of lipofuscin/lysosome‐like structures in patient brain.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> One patient underwent callosotomy with reported benefit.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> A number of patients with heterozygous <italic>KCTD7</italic> mutations and some overlapping neurological symptoms have also been identified, although any causal role for <italic>KCTD7</italic> in these cases is unknown.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Undiagnosed bi‐allelic <italic>KCTD7</italic> gene mutations have contributed to the misassignment of disease symptoms to unrelated events such as vaccinations routinely administered around the expected age of disease onset. In addition, the gene name for <italic>KCTDs</italic> has evoked assumptions that patients could be treated for a channelopathy,<xref ref-type="ref" rid="cns13156-bib-0046">46</xref> though currently available evidence does not justify this therapeutic approach.</p>
<p>Although the molecular mechanisms underlying disease in patients with <italic>KCTD7</italic> mutations are not known, research efforts have begun to dissect some biological functions. KCTD7 protein expression was reported in hippocampal neurons and Purkinje cells of mouse brain.<xref ref-type="ref" rid="cns13156-bib-0020">20</xref>, <xref ref-type="ref" rid="cns13156-bib-0041">41</xref> Expressed wild‐type KCTD7 protein in cultured mouse neurons or <italic>Xenopus</italic> oocytes was reported to hyperpolarize the resting cell membrane potential, and some patient mutations inhibited the K<sup>+</sup> flux observed with wild‐type KCTD7.<xref ref-type="ref" rid="cns13156-bib-0020">20</xref>, <xref ref-type="ref" rid="cns13156-bib-0023">23</xref> How KCTD7 might influence potassium currents is not known but may be indirect as compelling evidence of a direct interaction with K<sup>+</sup> channels is currently lacking. Cerebrospinal fluid from some patients was reported to have higher levels of glutamine and lower levels of glutamate, which was suggested to result from impaired regulation of the neuronal glutamine transporter SAT2 by mutant KCTD7.<xref ref-type="ref" rid="cns13156-bib-0023">23</xref>
</p>
<p>Our biochemical studies indicate that KCTD7 protein interacts with cullin‐3,<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>, <xref ref-type="ref" rid="cns13156-bib-0020">20</xref> raising the possibility that KCTD7 may serve as an adaptor for the cullin‐3 E3 ubiquitin ligase to mediate protein degradation of targeted substrates. However, no KCTD7‐recruited substrate proteins have been identified. One study implied that the C‐terminus of KCTD7 may be involved in binding cullin‐3.<xref ref-type="ref" rid="cns13156-bib-0036">36</xref> More recent evidence indicates that the BTB‐containing N‐terminus of KCTD7 is required and sufficient for cullin‐3 interactions based on co‐immunoprecipitation assays and subcellular localization of expressed proteins.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Furthermore, this interaction with cullin‐3 is partially impaired by BTB domain mutations found in patients (R70W, R84Q, L108M).<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Thus, a role for KCTD7 in proteostasis could conceivably contribute to progressive disease by causing the accumulation of undegraded proteins, correlating with the prevalence of abnormal lysosome‐like structures observed by electron microscopy in neurons of a patient brain biopsy.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Consistent with these findings, electron microscopy analysis of low‐passage skin fibroblasts derived from two additional KCTD7 patients exhibits abnormal mitochondrial cristae morphologies, lipid droplet accumulation around mitochondria, and phagolysosomes containing partially degraded material, features that were absent from matched control cells.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref>
</p>
<p>One potential mechanism to explain these observations arose from yeast genetic studies. Fungal Whi2 protein sequences and metazoan KCTD family sequences share a homologous BTB domain (IPR011333) with significant sequence similarity (Figures <xref ref-type="fig" rid="cns13156-fig-0001">1</xref>, <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>).<xref ref-type="ref" rid="cns13156-bib-0047">47</xref> It is not known whether both yeast and mammalian KCTD proteins descended from a common ancestral gene or whether they evolved as a result of BTB domain insertion into unrelated ancestral genes (therefore, they share sequence homology but are not referred to as homologs). The yeast <italic>WHI2</italic> gene from <italic>Saccharomyces cerevisiae</italic> was originally discovered when a spontaneous inactivating mutation in <italic>WHI2</italic> was identified as the cause for a cell growth phenotype.<xref ref-type="ref" rid="cns13156-bib-0048">48</xref>, <xref ref-type="ref" rid="cns13156-bib-0049">49</xref> Yeast <italic>WHI2</italic> was later rediscovered for similar reasons, because spontaneous <italic>WHI2</italic> mutations caused cells to continue growing inappropriately after switching cells to medium with low levels of amino acids.<xref ref-type="ref" rid="cns13156-bib-0050">50</xref> This is because Whi2 is required to suppress TORC1 kinase, the master regulator of cellular responses to nutrient status.<xref ref-type="ref" rid="cns13156-bib-0014">14</xref>, <xref ref-type="ref" rid="cns13156-bib-0015">15</xref>, <xref ref-type="ref" rid="cns13156-bib-0051">51</xref> Interestingly, knockdown of <italic>Kctd13</italic> in neuro2A cells was reported to increase cell proliferation.<xref ref-type="ref" rid="cns13156-bib-0052">52</xref> Whether KCTD13 or KCTD7 regulates TORC1, or whether this involves cullin‐3‐dependent protein degradation is not known. However, given that TORC1 is well known to actively suppress autophagy in yeast and mammals, it is not surprising that <italic>whi2</italic> ‐mutant yeast, which have sustained TORC1 activity in low amino acid conditions, fail to induce autophagy.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Interestingly, <italic>KCTD7</italic> patient fibroblasts were found to have defective autophagy induction when starved.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> Consistent with a role for BTB‐containing, cullin‐interacting proteins in autophagy regulation, the BTB‐kelch‐repeat protein KLHL20 regulates autophagy by functioning as a cullin‐3 adaptor to degrade the mTORC1‐inhibited ULK1 protein kinase and the lipid kinase VPS34, both important for early steps of autophagosome formation.<xref ref-type="ref" rid="cns13156-bib-0053">53</xref> Similarly, the F‐box protein and associated BTB/POZ protein Skp1 can mediate cullin‐1‐dependent degradation of VPS34 to regulate autophagy.<xref ref-type="ref" rid="cns13156-bib-0054">54</xref>
</p>
<p>Interestingly, a spontaneous <italic>whi2</italic> mutation in yeast partially rescues defective mitochondrial respiratory function (petite phenotype) caused by loss of the mitochondrial fission factor Fis1, also conserved in humans.<xref ref-type="ref" rid="cns13156-bib-0047">47</xref>, <xref ref-type="ref" rid="cns13156-bib-0050">50</xref> By promoting mitochondrial organelle fission, Fis1 is thought to promote turnover of mitochondria by generating small organelles that can be engulfed by autophagosomes.<xref ref-type="ref" rid="cns13156-bib-0055">55</xref>, <xref ref-type="ref" rid="cns13156-bib-0056">56</xref> Perhaps sustained TORC1 activity in <italic>fis1whi2</italic> double mutants helps compensate for mitochondrial insufficiency without Fis1, explaining why most <italic>FIS1</italic>‐deletion strains develop a secondary <italic>WHI2</italic> mutation.<xref ref-type="ref" rid="cns13156-bib-0050">50</xref> While the role of Whi2 versus Fis1 in mitochondrial turnover via mitophagy is debated,<xref ref-type="ref" rid="cns13156-bib-0057">57</xref>, <xref ref-type="ref" rid="cns13156-bib-0058">58</xref> the profound defect in autophagy observed in knockouts lacking Whi2 (yeast KCTD) provided the first clue about the function of human KCTD7 in autophagy. This model is consistent with the prevalence of mitochondria containing defective cristae membrane structures <xref ref-type="ref" rid="cns13156-bib-0013">13</xref> and the altered branching patterns of mitochondrial organelles observed in KCTD7 patient fibroblasts (Figure <xref ref-type="fig" rid="cns13156-fig-0004">4</xref>). In the future, animal models will likely be needed to understand the physiological and pathological consequences of <italic>Kctd7</italic> deficiency before grasping the organismal and behavioral consequences relevant to human disease mechanisms.</p>
<fig fig-type="Figure" id="cns13156-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>Altered mitochondrial morphology in <italic>KCTD7</italic> mutant patient fibroblasts. Primary passage‐matched human fibroblasts from (A) an age‐matched control and (B) a patient with compound heterozygous R84W/D106fs mutations in <italic>KCTD7</italic> were confirmed by Sanger sequencing and qRT‐PCR analysis as described.<xref ref-type="ref" rid="cns13156-bib-0013">13</xref> To visualize mitochondrial organelles, cells grown on round 12‐mm‐diameter glass coverslips (FisherBrand) were fixed (10 min in cold 4% paraformaldehyde), permeabilized (5 min with 0.2% Triton X‐100) and immunostained 1 h with anti‐Tom20 antibody and Alexa Fluor® secondary antibodies (Santa Cruz), mounted in Prolong Gold, and 0.5 μmol/L Z‐stack images were captured on a Nikon 90i at 40x or 60x magnification using Volocity software for deconvolution. (For quantification, mitochondria in some experiments were labeled instead with 100 nmol/L Mitotracker Red for 15 min prior to fixation.) Double‐blinded images were converted to 8‐bit grayscale, binarized and skeletonized using a custom ImageJ plug‐in, and mitochondrial structure parameters (including length, size, branching, degree of clustering, circularity) were quantified using “Analyze Skeleton 2D/3D” ImageJ plug‐in for 2‐3 independent experiments. The total mitochondrial network per cells was significantly reduced in long‐branch frequency in <italic>KCTD7</italic> mutant fibroblast compared to control fibroblast. Individual mitochondrial subnetworks (skeletons) are rainbow colored according to total length (red longest, blue shortest). Position of the nucleus in each cell is marked by a gray circle</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="CNS-25-887-g004"></graphic>
</fig>
</sec>
<sec id="cns13156-sec-0005">
<label>3.2</label>
<title>KCTD8, KCTD12, and KCTD16 in neurotransmitter receptor signaling</title>
<p>Mouse Kctd8, Kctd12, Kctd12b (not found in humans), and Kctd16 belong to clade F of the KCTD protein family (Figure <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>, Table <xref ref-type="table" rid="cns13156-tbl-0001">1</xref>)<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> and are considered auxiliary subunits of the inhibitory neurotransmitter receptor complex GABA<sub>B1/2</sub> (G‐protein‐coupled receptor/GPCR 3 family) present on both inhibitory and excitatory neurons.<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>, <xref ref-type="ref" rid="cns13156-bib-0059">59</xref> Supported by studies in GABA<sub>B</sub>‐deficient mice, GABA<sub>B</sub> receptor aberrations are implicated in neurodegenerative and neuropsychiatric disorders, including seizure disorders, depression, schizophrenia, addiction, and several neurodevelopmental disorders.<xref ref-type="ref" rid="cns13156-bib-0059">59</xref>, <xref ref-type="ref" rid="cns13156-bib-0060">60</xref>, <xref ref-type="ref" rid="cns13156-bib-0061">61</xref> Therefore, disruption of the auxiliary subunits KCTD8, KCTD12, and KCTD16 may cause related conditions. A mutation in the promoter region of human <italic>KCTD12</italic> was reported to contribute to bipolar I disorder.<xref ref-type="ref" rid="cns13156-bib-0062">62</xref> Similarly, elevated protein levels of human KCTD12 were associated with depression<xref ref-type="ref" rid="cns13156-bib-0063">63</xref> and schizophrenia.<xref ref-type="ref" rid="cns13156-bib-0064">64</xref> Consistent with these findings, <italic>kctd12</italic> ‐knockout mice exhibit related phenotypes including altered emotional behaviors and increased neuronal excitability,<xref ref-type="ref" rid="cns13156-bib-0065">65</xref> supporting a potential role for <italic>KCTD12</italic> in neuropsychiatric disorders. <italic>KCTD12</italic> has also been implicated in several cancers not discussed here.</p>
<p>Insights into the molecular mechanisms involved are at the forefront of understanding KCTD family protein functions, and recent structure determinations further advance the field overall. The homologous GABA<sub>B1</sub> and GABA<sub>B2</sub> receptors (<italic>GABBR1</italic> and <italic>GABBR2</italic>) function as heterodimers. GABA<sub>B1</sub> binds the inhibitory neurotransmitter gamma‐aminobutyric acid (GABA), and the GABA<sub>B2</sub> subunit interacts with G‐proteins for signaling. GABA<sub>B1/2</sub> receptors modulate synaptic transmission by indirectly regulating specific Ca<sup>2+</sup> and K<sup>+</sup> channels through trimeric G‐proteins.<xref ref-type="ref" rid="cns13156-bib-0066">66</xref> KCTD8, KCTD12, and KCTD16 can increase the activation rate of GABA<sub>B</sub> responses, and KCTD12 can cause fast desensitization of GABA<sub>B</sub> receptor responses.<xref ref-type="ref" rid="cns13156-bib-0017">17</xref>, <xref ref-type="ref" rid="cns13156-bib-0021">21</xref>, <xref ref-type="ref" rid="cns13156-bib-0067">67</xref> A new crystal structure containing the C‐terminus of GABA<sub>B2</sub> (amino acid residues 876‐913) reveals how the pentameric BTB domain of KCTD16 enwraps the cytoplasmic tail of the neurotransmitter receptor GABA<sub>B2</sub>.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref> The interaction with KCTD16 and also with KCTD12 is abolished by the BTB mutation Phe80Ala in KCTD16 and Phe87Ala in KCTD12, further validating the crystal structure.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref>
</p>
<p>The same study also connects KCTD proteins with trimeric G‐protein complexes, providing a model for how clade F KCTDs may transmit a signal to regulate potassium flux across the cell membrane. The conserved H1 and H2 homology regions were previously recognized in the C‐terminus of clade F proteins, except H2 is not present in the shorter KCTD12 C‐terminus (Figure <xref ref-type="fig" rid="cns13156-fig-0001">1</xref>).<xref ref-type="ref" rid="cns13156-bib-0021">21</xref> The KCTD12 H1 region was previously shown to be responsible for desensitization of GABA<sub>B</sub> receptor responses, whereas H2 domains of KCTD8 and KCTD16 have auto‐inhibitory effects on their H1 region.<xref ref-type="ref" rid="cns13156-bib-0021">21</xref> A new crystal structure of KCTD12 H1 bound to Gβ<sub>1</sub>γ<sub>2</sub> reveals an H1 pentamer surrounded by five Gβ<sub>1</sub>γ<sub>2</sub> dimers.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref> Taking the evidence together, the proposed model is that a KCTD12 pentamer dangles from the extended cytoplasmic tail of GABA<sub>B2</sub>, which is anchored in the cell membrane with GABA<sub>B1</sub>.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref> Upon GABA<sub>B1</sub> receptor stimulation, KCTD12 expels Gα from the inhibited trimeric G‐protein complex Gαβ<sub>1</sub>γ<sub>2</sub>, and membrane‐associated Gβ<sub>1</sub>γ<sub>2</sub> can rapidly activate the associated GIRK (G‐protein‐coupled inwardly rectifying K<sup>+</sup> channel). Then, rapid deactivation/desensitization of GIRK channels would subsequently occur when KCTD12 H1 sequesters Gβγ away from these channels.<xref ref-type="ref" rid="cns13156-bib-0019">19</xref> A role for KCTD12 in GABA<sub>B</sub>‐Gβγ signaling to regulate potassium channel activity is not mutually exclusive with a role as a cullin‐3 adaptor (e.g., to degrade Gα), except that the α2β3 loop of KCTD12 is predicted to interfere with cullin‐3 interactions.<xref ref-type="ref" rid="cns13156-bib-0016">16</xref> Therefore, any congruency between the cullin‐binding KCTDs and GTPase signaling KCTDs is currently unresolved but may represent independent functions of the same or different KCTD family proteins. However, it is tempting to consider that these functions could be present in the same KCTD protein to coordinate cellular functions.</p>
</sec>
<sec id="cns13156-sec-0006">
<label>3.3</label>
<title>KCTD13 association with autism and schizophrenia</title>
<p>Recent genetic studies have revealed copy‐number variations (CNV) in many genes in association with developmental brain disorders, intellectual disability, epilepsy, autism spectrum disorder, and schizophrenia.<xref ref-type="ref" rid="cns13156-bib-0068">68</xref>
<italic>KCTD13</italic> (also known as <italic>BACURD1</italic> or <italic>POLDIP1</italic>) is located in the 16p11.2 locus, which is known to contribute to risk of multiple neuropsychiatric disorders. Deletions of 16p11.2 are associated with epilepsy, autism, and autism spectrum disorder (ASD),<xref ref-type="ref" rid="cns13156-bib-0069">69</xref> while 16p11.2 duplications are associated with autism and schizophrenia.<xref ref-type="ref" rid="cns13156-bib-0070">70</xref> Interestingly, dosage effects of 16p11.2 appear to affect head size in humans, with deletions observed in macrocephaly and duplication observed in microcephaly.<xref ref-type="ref" rid="cns13156-bib-0070">70</xref>
</p>
<p>Zebrafish and mouse model systems have helped to overcome the major challenge of dissecting the individual contributions to disease of the many genes present 16p11.2 duplications/deletions. Zebrafish have been useful in other studies to investigate human dosage‐sensitive genes and can reflect anatomical phenotypes observed in early human development.<xref ref-type="ref" rid="cns13156-bib-0071">71</xref> Therefore, zebrafish were used to dissect human 16p11.2, which encompasses 29 genes that when deleted in humans can confer susceptibility to neurocognitive defects.<xref ref-type="ref" rid="cns13156-bib-0052">52</xref>, <xref ref-type="ref" rid="cns13156-bib-0069">69</xref> Results from overexpression of each of these 29 genes individually in zebrafish embryos identified a single gene, <italic>KCTD13</italic>, capable of inducing microcephaly, a phenotype of patients with 16p11.2 duplication.<xref ref-type="ref" rid="cns13156-bib-0052">52</xref> Conversely, transient suppression of the orthologous Zebrafish <italic>kctd13</italic> locus resulted in the reciprocal macrocephaly phenotype.<xref ref-type="ref" rid="cns13156-bib-0052">52</xref>, <xref ref-type="ref" rid="cns13156-bib-0072">72</xref>, <xref ref-type="ref" rid="cns13156-bib-0073">73</xref> The importance of <italic>Kctd13</italic> for cellular proliferation was confirmed in developing mouse brains. In contrast to these studies, others failed to detect increased brain size or increased neurogenesis in mice or zebrafish when the entire <italic>Kctd13</italic> locus was deleted in zebrafish or mice.<xref ref-type="ref" rid="cns13156-bib-0011">11</xref> The discrepancy between both lines of data may be due to different compensation mechanisms between knockdown approaches and genetic deletion, possible phenotypic differences between <italic>Kctd13</italic> knockdown in only a subset of neural progenitors versus complete genetic deletion of the <italic>Kctd13 locus</italic>, or alternatively, contributions from other genes located in 16p11.2.</p>
<p>Other studies demonstrate that in mouse models, <italic>Kctd13</italic> epistatically affects anatomical phenotypes in combination with <italic>Mvp</italic> (major vault protein) or <italic>Lat (linker for activation of T cells)</italic>, genes, which are also located in 16p11.2 loci<xref ref-type="ref" rid="cns13156-bib-0052">52</xref>, <xref ref-type="ref" rid="cns13156-bib-0074">74</xref>. However, recent studies reported no robust abnormalities in brain structure of mice with genetic ablation of <italic>Kctd13</italic>, and instead observed sex‐specific differences in brain volume of double heterozygous mice lacking one copy of <italic>Kctd13</italic> and one copy of either <italic>Lat</italic> or <italic>Mvp</italic>, also located in 16p11.2.<xref ref-type="ref" rid="cns13156-bib-0075">75</xref> These results suggest that altered dosage of <italic>Kctd13</italic>, and <italic>Mvp</italic> or <italic>Lat</italic> may have epistatic effects on brain size.</p>
<p>KCTD13 has been reported to function as a cullin‐3 adaptor for ubiquitination and degradation of RhoA, a small GTPase protein that is a key regulator of actin cytoskeleton and plays critical roles in neuronal development and synaptic function.<xref ref-type="ref" rid="cns13156-bib-0033">33</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref> Consistently, genetic deletion of the entire <italic>Kctd13</italic> gene has resulted in increased RhoA expression, the loss of dendritic spines and reduced synaptic activity in the CA1 region of the hippocampus.<xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0076">76</xref> Reduced synaptic transmission is normalized by pharmacological inhibition of RhoA. These results suggest that KCTD13 may recruit RhoA for modulating its turnover via the cullin‐3 ubiquitin ligase, thereby regulating synaptic function, consistent with spatiotemporal network analysis of brain subregions.<xref ref-type="ref" rid="cns13156-bib-0034">34</xref> This <italic>Kctd13</italic>‐knockout mouse (entire <italic>Kctd13</italic> gene deleted) lacked detectable memory deficits.<xref ref-type="ref" rid="cns13156-bib-0011">11</xref> However, an independently constructed <italic>Kctd13</italic>‐deficient mouse with an out‐of‐frame exon 2 deletion (expected to fully ablate <italic>Kctd13</italic>) exhibited deficits in short‐term recognition memory, but lacked detectable changes in expression levels of RhoA, the candidate KCTD13‐cullin target substrate.<xref ref-type="ref" rid="cns13156-bib-0075">75</xref> However, RNA‐seq analyses of gene expression profiles from the cortex and hippocampus of <italic>Kctd13</italic> ‐deficient (exon 2‐deleted) mice revealed altered signaling pathways critical for neurodevelopment, including synaptic formation, and both knockout mouse lines exhibited reduced spine density in the hippocampus.<xref ref-type="ref" rid="cns13156-bib-0011">11</xref>, <xref ref-type="ref" rid="cns13156-bib-0075">75</xref> Thus, further studies are required to understand the mechanistic complexities by which Kctd13 copy number modulates brain development beyond RhoA signaling. It would also be of great interest to investigate how multiple genes in 16p11.2 loci interplay to regulate brain development and contribute to neurodevelopmental abnormalities and psychiatric disorders such as schizophrenia and autism.</p>
</sec>
<sec id="cns13156-sec-0007">
<label>3.4</label>
<title>KCTD17 in myoclonus‐dystonia</title>
<p>Myoclonus‐dystonia syndrome (MDS) is a rare movement disorder characterized by nonepileptic spontaneous muscle contractions and dystonia.<xref ref-type="ref" rid="cns13156-bib-0077">77</xref> Approximately 25‐50% of myoclonus‐dystonia cases are caused by autosomal dominant mutations in the <italic>SGCE</italic> gene, coding for ε‐sarcoglycan.<xref ref-type="ref" rid="cns13156-bib-0078">78</xref> Thus, there are additional genetic variants responsible for this disease, and several candidate genes have been identified, some of which have been confirmed.<xref ref-type="ref" rid="cns13156-bib-0079">79</xref>, <xref ref-type="ref" rid="cns13156-bib-0080">80</xref>
<italic>KCTD17</italic> variant c.434G &gt; A, p.Arg145His was identified by combining genome‐wide linkage analysis and whole‐exome sequencing of a large British pedigree and of a second German family with autosomal dominant myoclonus‐dystonia but lacking <italic>SGCE</italic> gene mutations.<xref ref-type="ref" rid="cns13156-bib-0079">79</xref> Additional tests confirmed the lack of a common ancestor between these two families. <italic>KCTD17</italic> (c.434G &gt; A, p.Arg145His) was the only segregating variant among seven candidates from affected myoclonus‐dystonia patients in the British family.<xref ref-type="ref" rid="cns13156-bib-0079">79</xref> Very recently, two additional <italic>KCTD17</italic> mutations affecting the same splice acceptor site (c.508‐2A &gt; T and c.508‐1G &gt; T) were identified in two independent studies.<xref ref-type="ref" rid="cns13156-bib-0081">81</xref>, <xref ref-type="ref" rid="cns13156-bib-0082">82</xref> It has been pointed out that the clinical features of the <italic>KCTD17</italic> patients are phenotypically distinguishable from MDS due to <italic>SGCE</italic> mutations.<xref ref-type="ref" rid="cns13156-bib-0080">80</xref> However, the evidence is reasonably compelling that <italic>KCTD17</italic> mutations are responsible for a subset of myoclonus‐dystonia. Although autosomal dominant <italic>KCTD17</italic> mutations cause less severe disease than bi‐allelic <italic>KCTD7</italic> mutations discussed in section 3.1, both <italic>KCTD7</italic> and <italic>KCTD17</italic> disorders have some overlapping clinical features including difficulty swallowing, impaired verbal skills, cognitive impairment, difficulties with fine motor skills, and their disease is progressive, unlike SGCE mutations.</p>
<p>The biological functions of KCTD17 are not yet clear. <italic>KCTD17</italic> mRNA was shown to be broadly expressed across the brain but particularly in the putamen, consistent with dystonia being caused by dysfunction of basal ganglia circuits.<xref ref-type="ref" rid="cns13156-bib-0079">79</xref> Fibroblasts derived from a <italic>KCTD17</italic> patient (p.Arg145His) exhibit defective ER calcium signaling, which is suggested to underlie myoclonus‐dystonia linked to mutations in other genes (e.g.,<italic> HPCA</italic>, <italic>CACNA1A</italic>, <italic>ANO3</italic>).<xref ref-type="ref" rid="cns13156-bib-0079">79</xref>, <xref ref-type="ref" rid="cns13156-bib-0083">83</xref>
</p>
<p>KCTD17 has also been reported to function as an adaptor of the cullin‐3 ubiquitin ligase to mediate ubiquitination and degradation of trichoplein, which is a negative regulator of ciliogenesis.<xref ref-type="ref" rid="cns13156-bib-0032">32</xref> Both neurons and astrocytes contain a primary cilium, and ciliogenesis has been reported to play an important role in brain development.<xref ref-type="ref" rid="cns13156-bib-0084">84</xref> This raises the possibility that defective ciliogenesis caused by <italic>KCTD17</italic> mutations contributes to the pathology of myoclonus‐dystonia.</p>
<p>The BTB domain of mammalian KCTD17 is most similar in sequence to KCTD2, KCTD5, and KCTD9, which together constitute clade E (Figure <xref ref-type="fig" rid="cns13156-fig-0002">2</xref>, Table <xref ref-type="table" rid="cns13156-tbl-0001">1</xref>).<xref ref-type="ref" rid="cns13156-bib-0001">1</xref> Mammalian KCTD2, KCTD5, and KCTD17 are homologs of <italic>Drosophila</italic> Insomniac protein (Inc), a regulator of sleep homeostasis and synaptic function in flies.<xref ref-type="ref" rid="cns13156-bib-0085">85</xref> Insomniac was reported to be a substrate adaptor of <italic>Drosophila</italic> cullin‐3 and may regulate turnover of yet unknown neuronal targets to regulate sleep and synaptic functions.<xref ref-type="ref" rid="cns13156-bib-0085">85</xref> Both insomniac and its mammalian homologs are expressed in the nervous system and localize to synapses.<xref ref-type="ref" rid="cns13156-bib-0086">86</xref> Mouse KCTD2, KCTD5, and KCTD17 can each heteromultimerize with <italic>Drosophila</italic> Insomniac and also bind to <italic>Drosophila</italic> cullin‐3 in vitro<italic>,</italic> suggesting conserved functions.<xref ref-type="ref" rid="cns13156-bib-0086">86</xref> Although only mouse KCTD2 and KCTD5, but not KCTD17, were able to rescue the sleep phenotype in flies lacking <italic>Insomniac</italic>, the inability of KCTD17 to restore sleep in <italic>insomniac</italic> mutant flies was suggested to be due to its low expression in transgenic flies.<xref ref-type="ref" rid="cns13156-bib-0086">86</xref>
<italic>Drosophila</italic> Insomniac and cullin‐3 also regulate dopaminergic signaling.<xref ref-type="ref" rid="cns13156-bib-0085">85</xref> Dysfunction of dopaminergic pathways has been associated with myoclonus‐dystonia.<xref ref-type="ref" rid="cns13156-bib-0087">87</xref> Currently, the molecular links between KCTD17‐cullin3‐dependent protein degradation, synaptic function, dopaminergic signaling, and pathology of myoclonus‐dystonia remain unclear.</p>
</sec>
<sec id="cns13156-sec-0008">
<label>3.5</label>
<title>KCTD3 in neurocognitive disease</title>
<p>KCTD3, also known as NY‐REN‐45, has been identified in several genome‐wide screens for disease variants. A bi‐allelic frameshift mutation in <italic>KCTD3</italic> (c.1036_1073del, p.P346Tfs*4) was first identified in one family by whole exon sequencing of 143 multiplex families with neurocognitive disorders.<xref ref-type="ref" rid="cns13156-bib-0088">88</xref> This same <italic>KCTD3</italic> mutation was later reported in a 2.5‐year‐old patient.<xref ref-type="ref" rid="cns13156-bib-0089">89</xref> Homozygous <italic>KCTD3</italic> mutations were identified in three additional families, one harboring the same frameshift mutation (c.1036_1073del, p.P346Tfs*4), and the other two harboring a missense mutation (c.166C &gt; T, p.Arg56*).<xref ref-type="ref" rid="cns13156-bib-0090">90</xref>
<italic>KCTD3</italic> patients exhibit global developmental delay, seizures, and cerebellar hypoplasia.<xref ref-type="ref" rid="cns13156-bib-0088">88</xref>, <xref ref-type="ref" rid="cns13156-bib-0090">90</xref>
</p>
<p>The biological function of KCTD3 protein has not been investigated in‐depth, but one study provides some evidence that links KCTD3 with the nervous system. Mouse Kctd3 was identified as a binding partner of Hcn3 (hyperpolarization‐activated cyclic nucleotide‐gated channel) in a yeast two‐hybrid screen.<xref ref-type="ref" rid="cns13156-bib-0091">91</xref> Immunoprecipitation from mouse brain lysates suggests that Kctd3 specifically binds to Hcn3, but not to the other Hcn channels (Hcn1, Hcn2, and Hcn4).<xref ref-type="ref" rid="cns13156-bib-0091">91</xref> Immunostaining confirmed that Kctd3 and Hcn3 colocalize in several brain regions including hypothalamus, midbrain and cerebellum. Kctd3 increases Hcn3 current density by promoting trafficking of Hcn3 protein to the cell membrane.<xref ref-type="ref" rid="cns13156-bib-0091">91</xref> Human HCN channels are widely expressed in the brain and are reported to control cellular excitability and synaptic transmission.<xref ref-type="ref" rid="cns13156-bib-0092">92</xref>, <xref ref-type="ref" rid="cns13156-bib-0093">93</xref> Whether KCTD3 also regulates these neuronal functions is not yet known.</p>
</sec>
</sec>
<sec id="cns13156-sec-0009">
<label>4</label>
<title>RELEVANCE OF OTHER KCTD FAMILY MEMBERS TO THE NERVOUS SYSTEM</title>
<sec id="cns13156-sec-0010">
<label>4.1</label>
<title>KCTD11 in cancer</title>
<p>KCTD11 has been implicated as a tumor suppressor in several cancers, most notably in medulloblastoma, a primary brain tumor of childhood.<xref ref-type="ref" rid="cns13156-bib-0094">94</xref> Suggested mechanisms include KCTD11‐mediated suppression of the hedgehog signaling pathway by interacting with cullin‐3 via the BTB domain of KCTD11, while the KCTD11 C‐terminus recruits the Gli deacetylase HDAC1 for degradation.<xref ref-type="ref" rid="cns13156-bib-0012">12</xref>
<italic>KCTD11</italic> is located on 17p13.1 near <italic>TP53</italic>. In an in vivo mouse screen to test the effect of haploinsufficiency of <italic>TP53</italic>‐linked genes, mouse <italic>Kctd11</italic> was identified as a tumor suppressor gene.<xref ref-type="ref" rid="cns13156-bib-0095">95</xref> However, neither of these findings has been confirmed by follow‐up investigations.</p>
<p>Until very recently, human KCTD11 was annotated in the NCBI and UniProt databases as a 232 amino acid protein with a truncated BTB domain (currently annotated at NCBI as KCTD11s, NP_001002914). However, coding sequencings for the missing N‐terminal segment of the BTB domain are present in‐frame immediately preceding the most 5‐prime ATG start of translation. In vitro studies suggest that KCTD11 is translated from an upstream non‐AUG (AUU) start codon (which may occur more commonly than appreciated), adding 39 amino acids to the N‐terminus of human KCTD11.<xref ref-type="ref" rid="cns13156-bib-0096">96</xref> NCBI recently revised the annotation of human KCTD11 as a 271 amino acid protein including a full BTB domain (KCTD11l, NP_001350571). A recent study showed that yeast Whi2 sharing a BTB domain homologous to that of human KCTD proteins is capable of inhibiting TORC1 under low amino acid conditions.<xref ref-type="ref" rid="cns13156-bib-0014">14</xref> Remarkably, human KCTD11 but not other KCTD proteins tested (KCTD7, KCTD8, KCTD11, KCTD12, and KCTD16) could suppress TORC1 activity when expressed in <italic>whi2</italic> ‐deficient yeast and in mammalian cell lines under low amino acid conditions.<xref ref-type="ref" rid="cns13156-bib-0014">14</xref> Furthermore, knockdown of <italic>KCTD11</italic> in HEK293 cells confirmed that KCTD11 is required to suppress mTORC1 during amino acid deprivation.<xref ref-type="ref" rid="cns13156-bib-0014">14</xref> The detailed molecular mechanism of how KCTD11 regulates mTORC1 activity is still unknown. One speculation is that there is crosstalk between mTORC1 and the hedgehog signaling pathways through KCTD11 in cancer.</p>
</sec>
<sec id="cns13156-sec-0011">
<label>4.2</label>
<title>KCTD15 in neural crest formation and obesity</title>
<p>Genome‐wide association studies (GWAS) have identified <italic>KCTD15</italic> variants in association with increased risk of obesity.<xref ref-type="ref" rid="cns13156-bib-0097">97</xref>, <xref ref-type="ref" rid="cns13156-bib-0098">98</xref> Although the detailed molecular mechanisms are not known, several lines of evidence suggest a potential role for <italic>KCTD15</italic> in obesity through inhibition of Wnt signaling. KCTD15 was reported to control/limit neural crest formation in zebrafish and frog embryos by attenuating the Wnt‐β‐catenin signaling pathway, as overexpression of <italic>KCTD15</italic> decreased neural crest formation while <italic>KCTD15</italic> knockdown caused neural crest size to increase.<xref ref-type="ref" rid="cns13156-bib-0099">99</xref> Follow‐up studies carried out by the same group showed that in zebrafish embryos and in human cells, KCTD15 directly inhibits the transcription factor AP‐2α, a target of Wnt signaling, consistent with a role for KCTD15 in neural crest development.<xref ref-type="ref" rid="cns13156-bib-0010">10</xref> The proposed mechanism is that KCTD15 binds to the proline‐rich activation domain of AP‐2α to prevent transcriptional activation by AP‐2α and that SUMO modification in the C‐terminus of zebrafish Kctd15 on Lys252 (human K278) inhibits the ability of KCTD15 to suppress transcription and inhibit neural crest formation.<xref ref-type="ref" rid="cns13156-bib-0010">10</xref>, <xref ref-type="ref" rid="cns13156-bib-0100">100</xref> Given that mesenchymal stem cells and some adipocytes are derived from the neural crest,<xref ref-type="ref" rid="cns13156-bib-0101">101</xref> and that AP‐2 regulates the expression of genes important for adipogenesis, such as <italic>C/EBPα</italic> and <italic>IRS‐</italic> 1,<xref ref-type="ref" rid="cns13156-bib-0102">102</xref>, <xref ref-type="ref" rid="cns13156-bib-0103">103</xref> it is conceivable that KCTD15 may regulate adipogenesis by regulating AP‐2 transcription activity in neural crest during development.</p>
</sec>
</sec>
<sec id="cns13156-sec-0012">
<label>5</label>
<title>PERSPECTIVES</title>
<p>Several human <italic>KCTD</italic> family genes are expressed predominantly in the brain. Genetic alternations in <italic>KCTD</italic> family members have been associated with neurodevelopmental disorders, epilepsy, autism, schizophrenia, movement disorders, obesity, and several cancers, but little is understood about the biological functions of KCTD family proteins (Table <xref ref-type="table" rid="cns13156-tbl-0001">1</xref>). The original expectation that BTB domains of KCTD family members might directly partner with their nearest homologs, the T1/BTB domains of voltage‐gated potassium channels, currently lacks confirmation. However, new evidence supports roles for KCTDs in signaling pathways to indirectly modulate potassium channel activity. KCTDs appear to be involved in other processes, including nutrient sensing and autophagy, based on work in yeast showing that the yeast KCTD‐like protein Whi2 interacts with yeast phosphatases Psr1/Psr2 to regulate TORC1 activity.<xref ref-type="ref" rid="cns13156-bib-0014">14</xref> The plethora of effects of KCTD family proteins may reflect an adaptor function of KCTDs that recruits substrates for ubiquitination by cullin‐3 and subsequent degradation, though evidence also supports additional mechanisms. The highly variable C‐terminal regions of KCTD proteins could potentially reflect their roles in recruiting diverse substrates for cullin‐3‐mediated ubiquitination and degradation, though this is only one possibility. A binding site of the heterotrimeric G‐protein subunits Gβγ has been mapped to the C‐terminus of KCTD12 and KCTD16. Though it is not known whether this interaction serves only to desensitize the G‐protein coupled inwardly rectifying potassium channel GIRK or whether KCTD‐mediated protein turnover or other functions are involved. Defects in ubiquitination‐dependent protein function and/or GTPase modulated ion flux may underlie the neurodevelopmental and neuropsychiatric disorders associated with mutations affecting KCTD family proteins. In addition, more animal models are needed to understand pathophysiological roles of KCTDs before comprehending the detailed mechanisms of human disease.</p>
<p>Difficulties in diagnosing children with rare disease mutations in KCTD proteins have contributed to the misassignment of symptoms to other causes. The early‐onset age for autism and several other KCTD‐associated disorders coincide with the timing of childhood vaccinations. Consequently, patient narratives and social media indicate that these families spent years without an explanation for their child's illness. Patients with undiagnosed disease mutations seek explanations from circumstantial evidence. For example, until 2012 there was only a single publication implicating <italic>KCTD7</italic> mutations in disease.<xref ref-type="ref" rid="cns13156-bib-0038">38</xref> Similarly, a separate cohort of patients with encephalopathies attributed to vaccine reactions were instead due to de novo mutations in SCN1A.<xref ref-type="ref" rid="cns13156-bib-0104">104</xref>, <xref ref-type="ref" rid="cns13156-bib-0105">105</xref> Thus, from a policy perspective as well as from a therapeutic perspective, new knowledge about KCTD family protein functions is urgently needed.</p>
</sec>
<sec id="cns13156-sec-0013" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>The authors have no conflicts of interest to declare.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="cns13156-sup-0001">
<caption>
<p>Table S1. BTB amino acid sequences used to generate figures 1 and 2. </p>
</caption>
<media xlink:href="CNS-25-887-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="cns13156-sup-0002">
<caption>
<p>Table S2. BTB alignment used for the analysis presented in figure 2. </p>
</caption>
<media xlink:href="CNS-25-887-s002.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="cns13156-sec-0014">
<title>ACKNOWLEDGMENTS</title>
<p>Supported by the National Natural Science Foundation of China 31401197, Jiangsu Key Laboratory of Neuropsychiatric Diseases BM2013003, and the Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD) to X.T., by the Fondation ARC and the Ligue Contre le Cancer Comité du Gard to A.A., by the National Institutes of Health USA grants P50MH094268 and R01DA041208 to A.K., R01NS083373 and R01GM077875 to J.M.H., and the Wendy Klag Center for Autism and Developmental Disabilities to J.M.H.</p>
</ack>
<ref-list content-type="cited-references" id="cns13156-bibl-0001">
<title>REFERENCES</title>
<ref id="cns13156-bib-0001">
<label>1</label>
<mixed-citation id="cns13156-cit-0001" publication-type="journal">
<string-name>
<surname>Skoblov</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marakhonov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Marakasova</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development</article-title>. <source xml:lang="en"/>BioEssays. <year>2013</year>;<volume>35</volume>(<issue>7</issue>):<fpage>586</fpage>‐<lpage>596</lpage>.<pub-id pub-id-type="pmid">23592240</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0002">
<label>2</label>
<mixed-citation id="cns13156-cit-0002" publication-type="journal">
<string-name>
<surname>Ji</surname>
<given-names>AX</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Benlekbir</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rubinstein</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Prive</surname>
<given-names>GG</given-names>
</string-name>. <article-title>Structural insights into KCTD protein assembly and cullin3 recognition</article-title>. <source xml:lang="en"/>J Mol Biol. <year>2016</year>;<volume>428</volume>(<issue>1</issue>):<fpage>92</fpage>‐<lpage>107</lpage>.<pub-id pub-id-type="pmid">26334369</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0003">
<label>3</label>
<mixed-citation id="cns13156-cit-0003" publication-type="journal">
<string-name>
<surname>Dementieva</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Tereshko</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>McCrossan</surname>
<given-names>ZA</given-names>
</string-name>, et al. <article-title>Pentameric assembly of potassium channel tetramerization domain‐containing protein 5</article-title>. <source xml:lang="en"/>J Mol Biol. <year>2009</year>;<volume>387</volume>(<issue>1</issue>):<fpage>175</fpage>‐<lpage>191</lpage>.<pub-id pub-id-type="pmid">19361449</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0004">
<label>4</label>
<mixed-citation id="cns13156-cit-0004" publication-type="journal">
<string-name>
<surname>Bayón</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Trinidad</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>de la Puerta</surname>
<given-names>ML</given-names>
</string-name>, et al. <article-title>KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases</article-title>. <source xml:lang="en"/>FEBS J. <year>2008</year>;<volume>275</volume>(<issue>15</issue>):<fpage>3900</fpage>‐<lpage>3910</lpage>.<pub-id pub-id-type="pmid">18573101</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0005">
<label>5</label>
<mixed-citation id="cns13156-cit-0005" publication-type="journal">
<string-name>
<surname>Pinkas</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Sanvitale</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Bufton</surname>
<given-names>JC</given-names>
</string-name>, et al. <article-title>Structural complexity in the KCTD family of Cullin3‐dependent E3 ubiquitin ligases</article-title>. <source xml:lang="en"/>Biochem J. <year>2017</year>;<volume>474</volume>(<issue>22</issue>):<fpage>3747</fpage>‐<lpage>3761</lpage>.<pub-id pub-id-type="pmid">28963344</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0006">
<label>6</label>
<mixed-citation id="cns13156-cit-0006" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>YI</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>KCTD10 interacts with proliferating cell nuclear antigen and its down‐regulation could inhibit cell proliferation</article-title>. <source xml:lang="en"/>J Cell Biochem. <year>2009</year>;<volume>106</volume>(<issue>3</issue>):<fpage>409</fpage>‐<lpage>413</lpage>.<pub-id pub-id-type="pmid">19125419</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0007">
<label>7</label>
<mixed-citation id="cns13156-cit-0007" publication-type="journal">
<string-name>
<surname>He</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>CK</given-names>
</string-name>, <string-name>
<surname>Downey</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>So</surname>
<given-names>AG</given-names>
</string-name>. <article-title>A tumor necrosis factor alpha‐ and interleukin 6‐inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>2001</year>;<volume>98</volume>(<issue>21</issue>):<fpage>11979</fpage>‐<lpage>11984</lpage>.<pub-id pub-id-type="pmid">11593007</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0008">
<label>8</label>
<mixed-citation id="cns13156-cit-0008" publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>CK2 phosphorylates TNFAIP1 to affect its subcellular localization and interaction with PCNA</article-title>. <source xml:lang="en"/>Mol Biol Rep. <year>2010</year>;<volume>37</volume>(<issue>6</issue>):<fpage>2967</fpage>‐<lpage>2973</lpage>.<pub-id pub-id-type="pmid">19851886</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0009">
<label>9</label>
<mixed-citation id="cns13156-cit-0009" publication-type="journal">
<string-name>
<surname>Ding</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>The interaction of KCTD1 with transcription factor AP‐2alpha inhibits its transactivation</article-title>. <source xml:lang="en"/>J Cell Biochem. <year>2009</year>;<volume>106</volume>(<issue>2</issue>):<fpage>285</fpage>‐<lpage>295</lpage>.<pub-id pub-id-type="pmid">19115315</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0010">
<label>10</label>
<mixed-citation id="cns13156-cit-0010" publication-type="journal">
<string-name>
<surname>Zarelli</surname>
<given-names>VE</given-names>
</string-name>, <string-name>
<surname>Dawid</surname>
<given-names>IB</given-names>
</string-name>. <article-title>Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP‐2</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>2013</year>;<volume>110</volume>(<issue>8</issue>):<fpage>2870</fpage>‐<lpage>2875</lpage>.<pub-id pub-id-type="pmid">23382213</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0011">
<label>11</label>
<mixed-citation id="cns13156-cit-0011" publication-type="journal">
<string-name>
<surname>Escamilla</surname>
<given-names>CO</given-names>
</string-name>, <string-name>
<surname>Filonova</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>AK</given-names>
</string-name>, et al. <article-title>Kctd13 deletion reduces synaptic transmission via increased RhoA</article-title>. <source xml:lang="en"/>Nature. <year>2017</year>;<volume>551</volume>:<fpage>227</fpage>‐<lpage>231</lpage>.<pub-id pub-id-type="pmid">29088697</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0012">
<label>12</label>
<mixed-citation id="cns13156-cit-0012" publication-type="journal">
<string-name>
<surname>Canettieri</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Di Marcotullio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Greco</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Histone deacetylase and Cullin3‐REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation</article-title>. <source xml:lang="en"/>Nat Cell Biol. <year>2010</year>;<volume>12</volume>(<issue>2</issue>):<fpage>132</fpage>‐<lpage>142</lpage>.<pub-id pub-id-type="pmid">20081843</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0013">
<label>13</label>
<mixed-citation id="cns13156-cit-0013" publication-type="journal">
<string-name>
<surname>Metz</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Coppens</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy‐lysosome defect</article-title>. <source xml:lang="en"/>Ann Neurol. <year>2018</year>;<volume>84</volume>(<issue>5</issue>):<fpage>766</fpage>‐<lpage>780</lpage>.<pub-id pub-id-type="pmid">30295347</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0014">
<label>14</label>
<mixed-citation id="cns13156-cit-0014" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>YU</given-names>
</string-name>, et al. <article-title>Whi2 is a conserved negative regulator of TORC1 in response to low amino acids</article-title>. <source xml:lang="en"/>PLoS Genet. <year>2018</year>;<volume>14</volume>(<issue>8</issue>):<fpage>e1007592</fpage>.<pub-id pub-id-type="pmid">30142151</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0015">
<label>15</label>
<mixed-citation id="cns13156-cit-0015" publication-type="journal">
<string-name>
<surname>Teng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hardwick</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Whi2: a new player in amino acid sensing</article-title>. <source xml:lang="en"/>Curr Genet. <year>2019</year>;<volume>65</volume>(<issue>3</issue>):<fpage>701</fpage>‐<lpage>709</lpage>.<pub-id pub-id-type="pmid">30701278</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0016">
<label>16</label>
<mixed-citation id="cns13156-cit-0016" publication-type="journal">
<string-name>
<surname>Smaldone</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pirone</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Balasco</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Di Gaetano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pedone</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Vitagliano</surname>
<given-names>L</given-names>
</string-name>. <article-title>Cullin 3 recognition is not a universal property among KCTD proteins</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2015</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e0126808</fpage>.<pub-id pub-id-type="pmid">25974686</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0017">
<label>17</label>
<mixed-citation id="cns13156-cit-0017" publication-type="journal">
<string-name>
<surname>Schwenk</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Metz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zolles</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits</article-title>. <source xml:lang="en"/>Nature. <year>2010</year>;<volume>465</volume>(<issue>7295</issue>):<fpage>231</fpage>‐<lpage>235</lpage>.<pub-id pub-id-type="pmid">20400944</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0018">
<label>18</label>
<mixed-citation id="cns13156-cit-0018" publication-type="journal">
<string-name>
<surname>Brockmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Blomen</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Nieuwenhuis</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Genetic wiring maps of single‐cell protein states reveal an off‐switch for GPCR signalling</article-title>. <source xml:lang="en"/>Nature. <year>2017</year>;<volume>546</volume>(<issue>7657</issue>):<fpage>307</fpage>‐<lpage>311</lpage>.<pub-id pub-id-type="pmid">28562590</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0019">
<label>19</label>
<mixed-citation id="cns13156-cit-0019" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Abreu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Levitz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kruse</surname>
<given-names>AC</given-names>
</string-name>. <article-title>Structural basis for KCTD‐mediated rapid desensitization of GABAB signalling</article-title>. <source xml:lang="en"/>Nature. <year>2019</year>;<volume>567</volume>(<issue>7746</issue>):<fpage>127</fpage>‐<lpage>131</lpage>.<pub-id pub-id-type="pmid">30814734</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0020">
<label>20</label>
<mixed-citation id="cns13156-cit-0020" publication-type="journal">
<string-name>
<surname>Azizieh</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Orduz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Van Bogaert</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Progressive myoclonic epilepsy‐associated gene KCTD7 is a regulator of potassium conductance in neurons</article-title>. <source xml:lang="en"/>Mol Neurobiol. <year>2011</year>;<volume>44</volume>(<issue>1</issue>):<fpage>111</fpage>‐<lpage>121</lpage>.<pub-id pub-id-type="pmid">21710140</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0021">
<label>21</label>
<mixed-citation id="cns13156-cit-0021" publication-type="journal">
<string-name>
<surname>Seddik</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jungblut</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Silander</surname>
<given-names>OK</given-names>
</string-name>, et al. <article-title>Opposite effects of KCTD subunit domains on GABA(B) receptor‐mediated desensitization</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2012</year>;<volume>287</volume>(<issue>47</issue>):<fpage>39869</fpage>‐<lpage>39877</lpage>.<pub-id pub-id-type="pmid">23035119</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0022">
<label>22</label>
<mixed-citation id="cns13156-cit-0022" publication-type="journal">
<string-name>
<surname>Turecek</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Schwenk</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fritzius</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Auxiliary GABAB receptor subunits uncouple G protein betagamma subunits from effector channels to induce desensitization</article-title>. <source xml:lang="en"/>Neuron. <year>2014</year>;<volume>82</volume>(<issue>5</issue>):<fpage>1032</fpage>‐<lpage>1044</lpage>.<pub-id pub-id-type="pmid">24836506</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0023">
<label>23</label>
<mixed-citation id="cns13156-cit-0023" publication-type="journal">
<string-name>
<surname>Moen</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Fjaer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hamdani</surname>
<given-names>EH</given-names>
</string-name>, et al. <article-title>Pathogenic variants in KCTD7 perturb neuronal K+ fluxes and glutamine transport</article-title>. <source xml:lang="en"/>Brain. <year>2016</year>;<volume>139</volume>(<issue>Pt 12</issue>):<fpage>3109</fpage>‐<lpage>3120</lpage>.<pub-id pub-id-type="pmid">27742667</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0024">
<label>24</label>
<mixed-citation id="cns13156-cit-0024" publication-type="journal">
<string-name>
<surname>Holmstrom</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Kostov</surname>
<given-names>RV</given-names>
</string-name>, <string-name>
<surname>Dinkova‐Kostova</surname>
<given-names>AT</given-names>
</string-name>. <article-title>The multifaceted role of Nrf2 in mitochondrial function</article-title>. <source xml:lang="en"/>Curr Opin Toxicol. <year>2016</year>;<volume>1</volume>:<fpage>80</fpage>‐<lpage>91</lpage>.<pub-id pub-id-type="pmid">28066829</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0025">
<label>25</label>
<mixed-citation id="cns13156-cit-0025" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Schulman</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Structure of the Cul1‐Rbx1‐Skp1‐F boxSkp2 SCF ubiquitin ligase complex</article-title>. <source xml:lang="en"/>Nature. <year>2002</year>;<volume>416</volume>(<issue>6882</issue>):<fpage>703</fpage>‐<lpage>709</lpage>.<pub-id pub-id-type="pmid">11961546</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0026">
<label>26</label>
<mixed-citation id="cns13156-cit-0026" publication-type="journal">
<string-name>
<surname>Zhuang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Calabrese</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Structures of SPOP‐substrate complexes: insights into molecular architectures of BTB‐Cul3 ubiquitin ligases</article-title>. <source xml:lang="en"/>Mol Cell. <year>2009</year>;<volume>36</volume>(<issue>1</issue>):<fpage>39</fpage>‐<lpage>50</lpage>.<pub-id pub-id-type="pmid">19818708</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0027">
<label>27</label>
<mixed-citation id="cns13156-cit-0027" publication-type="journal">
<string-name>
<surname>Scott</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Rhee</surname>
<given-names>DY</given-names>
</string-name>, <string-name>
<surname>Duda</surname>
<given-names>DM</given-names>
</string-name>, et al. <article-title>Two distinct types of E3 ligases work in unison to regulate substrate ubiquitylation</article-title>. <source xml:lang="en"/>Cell. <year>2016</year>;<volume>166</volume>(<issue>5</issue>):<fpage> 1198</fpage>‐<lpage>1214</lpage> e1124.<pub-id pub-id-type="pmid">27565346</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0028">
<label>28</label>
<mixed-citation id="cns13156-cit-0028" publication-type="journal">
<string-name>
<surname>Cheng</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Functional analysis of Cullin 3 E3 ligases in tumorigenesis</article-title>. <source xml:lang="en"/>Biochim Biophys Acta Rev Cancer. <year>2018</year>;<volume>1869</volume>(<issue>1</issue>):<fpage>11</fpage>‐<lpage>28</lpage>.<pub-id pub-id-type="pmid">29128526</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0029">
<label>29</label>
<mixed-citation id="cns13156-cit-0029" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>H</given-names>
</string-name>. <article-title>KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c‐Myc</article-title>. <source xml:lang="en"/>Cell Death Differ. <year>2017</year>;<volume>24</volume>(<issue>4</issue>):<fpage>649</fpage>‐<lpage>659</lpage>.<pub-id pub-id-type="pmid">28060381</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0030">
<label>30</label>
<mixed-citation id="cns13156-cit-0030" publication-type="journal">
<string-name>
<surname>De Smaele</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Di Marcotullio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Moretti</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma</article-title>. <source xml:lang="en"/>Neoplasia. <year>2011</year>;<volume>13</volume>(<issue>4</issue>):<fpage>374</fpage>‐<lpage>385</lpage>.<pub-id pub-id-type="pmid">21472142</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0031">
<label>31</label>
<mixed-citation id="cns13156-cit-0031" publication-type="journal">
<string-name>
<surname>Kovačević</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sakaue</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Majoleé</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>The Cullin‐3‐Rbx1‐KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB</article-title>. <source xml:lang="en"/>J Cell Biol. <year>2018</year>;<volume>217</volume>(<issue>3</issue>):<fpage>1015</fpage>‐<lpage>1032</lpage>.<pub-id pub-id-type="pmid">29358211</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0032">
<label>32</label>
<mixed-citation id="cns13156-cit-0032" publication-type="journal">
<string-name>
<surname>Kasahara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kawakami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kiyono</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Ubiquitin‐proteasome system controls ciliogenesis at the initial step of axoneme extension</article-title>. <source xml:lang="en"/>Nat Commun. <year>2014</year>;<volume>5</volume>:<fpage>5081</fpage>.<pub-id pub-id-type="pmid">25270598</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0033">
<label>33</label>
<mixed-citation id="cns13156-cit-0033" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement</article-title>. <source xml:lang="en"/>Mol Cell. <year>2009</year>;<volume>35</volume>(<issue>6</issue>):<fpage>841</fpage>‐<lpage>855</lpage>.<pub-id pub-id-type="pmid">19782033</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0034">
<label>34</label>
<mixed-citation id="cns13156-cit-0034" publication-type="journal">
<string-name>
<surname>Lin</surname>
<given-names>GN</given-names>
</string-name>, <string-name>
<surname>Corominas</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lemmens</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Spatiotemporal 16p11.2 protein network implicates cortical late mid‐fetal brain development and KCTD13‐Cul3‐RhoA pathway in psychiatric diseases</article-title>. <source xml:lang="en"/>Neuron. <year>2015</year>;<volume>85</volume>(<issue>4</issue>):<fpage>742</fpage>‐<lpage>754</lpage>.<pub-id pub-id-type="pmid">25695269</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0035">
<label>35</label>
<mixed-citation id="cns13156-cit-0035" publication-type="journal">
<string-name>
<surname>Murakami</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Maekawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawai</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Cullin‐3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2‐positive breast cancer cells</article-title>. <source xml:lang="en"/>Cancer Sci. <year>2019</year>;<volume>110</volume>(<issue>2</issue>):<fpage>650</fpage>‐<lpage>661</lpage>.<pub-id pub-id-type="pmid">30515933</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0036">
<label>36</label>
<mixed-citation id="cns13156-cit-0036" publication-type="journal">
<string-name>
<surname>Staropoli</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Karaa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>ET</given-names>
</string-name>, et al. <article-title>A Homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin‐proteasome system</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>2012</year>;<volume>91</volume>(<issue>1</issue>):<fpage>202</fpage>‐<lpage>208</lpage>.<pub-id pub-id-type="pmid">22748208</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0037">
<label>37</label>
<mixed-citation id="cns13156-cit-0037" publication-type="journal">
<string-name>
<surname>Balasco</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Pirone</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Smaldone</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Molecular recognition of Cullin3 by KCTDs: insights from experimental and computational investigations</article-title>. <source xml:lang="en"/>Biochim Biophys Acta. <year>2014</year>;<volume>1844</volume>(<issue>7</issue>):<fpage>1289</fpage>‐<lpage>1298</lpage>.<pub-id pub-id-type="pmid">24747150</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0038">
<label>38</label>
<mixed-citation id="cns13156-cit-0038" publication-type="journal">
<string-name>
<surname>Van Bogaert</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Azizieh</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Désir</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Mutation of a potassium channel‐related gene in progressive myoclonic epilepsy</article-title>. <source xml:lang="en"/>Ann Neurol. <year>2007</year>;<volume>61</volume>(<issue>6</issue>):<fpage>579</fpage>‐<lpage>586</lpage>.<pub-id pub-id-type="pmid">17455289</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0039">
<label>39</label>
<mixed-citation id="cns13156-cit-0039" publication-type="journal">
<string-name>
<surname>Farhan</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>JF</given-names>
</string-name>, et al. <article-title>Linkage analysis and exome sequencing identify a novel mutation in KCTD7 in patients with progressive myoclonus epilepsy with ataxia</article-title>. <source xml:lang="en"/>Epilepsia. <year>2014</year>;<volume>55</volume>(<issue>9</issue>):<fpage>e106</fpage>‐<lpage>111</lpage>.<pub-id pub-id-type="pmid">25060828</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0040">
<label>40</label>
<mixed-citation id="cns13156-cit-0040" publication-type="journal">
<string-name>
<surname>Krabichler</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Rostasy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Baumann</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy</article-title>. <source xml:lang="en"/>Ann Hum Genet. <year>2012</year>;<volume>76</volume>(<issue>4</issue>):<fpage>326</fpage>‐<lpage>331</lpage>.<pub-id pub-id-type="pmid">22606975</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0041">
<label>41</label>
<mixed-citation id="cns13156-cit-0041" publication-type="journal">
<string-name>
<surname>Kousi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Anttila</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Schulz</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene</article-title>. <source xml:lang="en"/>J Med Genet. <year>2012</year>;<volume>49</volume>(<issue>6</issue>):<fpage>391</fpage>‐<lpage>399</lpage>.<pub-id pub-id-type="pmid">22693283</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0042">
<label>42</label>
<mixed-citation id="cns13156-cit-0042" publication-type="journal">
<string-name>
<surname>Vairo</surname>
<given-names>FP</given-names>
</string-name>, <string-name>
<surname>Boczek</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Cousin</surname>
<given-names>MA</given-names>
</string-name>, et al. <article-title>The prevalence of diseases caused by lysosome‐related genes in a cohort of undiagnosed patients</article-title>. <source xml:lang="en"/>Mol Genet Metab Rep. <year>2017</year>;<volume>13</volume>:<fpage>46</fpage>‐<lpage>51</lpage>.<pub-id pub-id-type="pmid">28831385</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0043">
<label>43</label>
<mixed-citation id="cns13156-cit-0043" publication-type="journal">
<string-name>
<surname>Ebrahimi‐Fakhari</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hildebrandt</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Rodan</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Anselm</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bodamer</surname>
<given-names>O</given-names>
</string-name>. <article-title>The spectrum of movement disorders in childhood‐onset lysosomal storage diseases</article-title>. <source xml:lang="en"/>Mov Disord Clin Pract. <year>2018</year>;<volume>5</volume>(<issue>2</issue>):<fpage>149</fpage>‐<lpage>155</lpage>.<pub-id pub-id-type="pmid">29930972</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0044">
<label>44</label>
<mixed-citation id="cns13156-cit-0044" publication-type="journal">
<string-name>
<surname>Lindy</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Stosser</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders</article-title>. <source xml:lang="en"/>Epilepsia. <year>2018</year>;<volume>59</volume>(<issue>5</issue>):<fpage>1062</fpage>‐<lpage>1071</lpage>.<pub-id pub-id-type="pmid">29655203</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0045">
<label>45</label>
<mixed-citation id="cns13156-cit-0045" publication-type="journal">
<string-name>
<surname>Mastrangelo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sartori</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Simonati</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: The multifaceted phenotypic spectrum of KCTD7‐related disorders</article-title>. <source xml:lang="en"/>Eur J Med Genet. <year>2018</year>.</mixed-citation>
</ref>
<ref id="cns13156-bib-0046">
<label>46</label>
<mixed-citation id="cns13156-cit-0046" publication-type="journal">
<string-name>
<surname>Oyrer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Petrou</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reid</surname>
<given-names>CA</given-names>
</string-name>. <article-title>Ion channels in genetic epilepsy: from genes and mechanisms to disease‐targeted therapies</article-title>. <source xml:lang="en"/>Pharmacol Rev. <year>2018</year>;<volume>70</volume>(<issue>1</issue>):<fpage>142</fpage>‐<lpage>173</lpage>.<pub-id pub-id-type="pmid">29263209</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0047">
<label>47</label>
<mixed-citation id="cns13156-cit-0047" publication-type="journal">
<string-name>
<surname>Teng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Dayhoff‐Brannigan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>W‐C</given-names>
</string-name>, et al. <article-title>Genome‐wide consequences of deleting any single gene</article-title>. <source xml:lang="en"/>Mol Cell. <year>2013</year>;<volume>52</volume>(<issue>4</issue>):<fpage>485</fpage>‐<lpage>494</lpage>.<pub-id pub-id-type="pmid">24211263</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0048">
<label>48</label>
<mixed-citation id="cns13156-cit-0048" publication-type="journal">
<string-name>
<surname>Sudbery</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Goodey</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>BL</given-names>
</string-name>. <article-title>Genes which control cell proliferation in the yeast <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source xml:lang="en"/>Nature. <year>1980</year>;<volume>288</volume>(<issue>5789</issue>):<fpage>401</fpage>‐<lpage>404</lpage>.<pub-id pub-id-type="pmid">7001255</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0049">
<label>49</label>
<mixed-citation id="cns13156-cit-0049" publication-type="journal">
<string-name>
<surname>Saul</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Walton</surname>
<given-names>EF</given-names>
</string-name>, <string-name>
<surname>Sudbery</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>B</given-names>
</string-name>. <article-title>
<italic>Saccharomyces cerevisiae whi2</italic> mutants in stationary phase retain the properties of exponentially growing cells</article-title>. <source xml:lang="en"/>J Gen Microbiol. <year>1985</year>;<volume>131</volume>:<fpage>2245</fpage>‐<lpage>2251</lpage>.</mixed-citation>
</ref>
<ref id="cns13156-bib-0050">
<label>50</label>
<mixed-citation id="cns13156-cit-0050" publication-type="journal">
<string-name>
<surname>Cheng</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Tucker</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Dunham</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Hardwick</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Fis1 deficiency selects for compensatory mutations responsible for cell death and growth control defects</article-title>. <source xml:lang="en"/>Cell Death Differ. <year>2008</year>;<volume>15</volume>(<issue>12</issue>):<fpage>1838</fpage>‐<lpage>1846</lpage>.<pub-id pub-id-type="pmid">18756280</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0051">
<label>51</label>
<mixed-citation id="cns13156-cit-0051" publication-type="journal">
<string-name>
<surname>Teng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yau</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sing</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hardwick</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Whi2 signals low leucine availability to halt yeast growth and cell death</article-title>. <source xml:lang="en"/>FEMS Yeast Res. <year>2018</year>;<volume>18</volume>(<issue>8</issue>):<fpage>887</fpage>‐<lpage>11</lpage>.</mixed-citation>
</ref>
<ref id="cns13156-bib-0052">
<label>52</label>
<mixed-citation id="cns13156-cit-0052" publication-type="journal">
<string-name>
<surname>Golzio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Willer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Talkowski</surname>
<given-names>ME</given-names>
</string-name>, et al. <article-title>KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant</article-title>. <source xml:lang="en"/>Nature. <year>2012</year>;<volume>485</volume>(<issue>7398</issue>):<fpage>363</fpage>‐<lpage>367</lpage>.<pub-id pub-id-type="pmid">22596160</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0053">
<label>53</label>
<mixed-citation id="cns13156-cit-0053" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>YH</given-names>
</string-name>, et al. <article-title>Cul3‐KLHL20 ubiquitin ligase governs the turnover of ULK1 and VPS34 complexes to control autophagy termination</article-title>. <source xml:lang="en"/>Mol Cell. <year>2016</year>;<volume>61</volume>(<issue>1</issue>):<fpage>84</fpage>‐<lpage>97</lpage>.<pub-id pub-id-type="pmid">26687681</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0054">
<label>54</label>
<mixed-citation id="cns13156-cit-0054" publication-type="journal">
<string-name>
<surname>Xiao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>FBXL20‐mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation</article-title>. <source xml:lang="en"/>Genes Dev. <year>2015</year>;<volume>29</volume>(<issue>2</issue>):<fpage>184</fpage>‐<lpage>196</lpage>.<pub-id pub-id-type="pmid">25593308</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0055">
<label>55</label>
<mixed-citation id="cns13156-cit-0055" publication-type="journal">
<string-name>
<surname>Mao</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Participation of mitochondrial fission during mitophagy</article-title>. <source xml:lang="en"/>Cell Cycle. <year>2013</year>;<volume>12</volume>(<issue>19</issue>):<fpage>3131</fpage>‐<lpage>3132</lpage>.<pub-id pub-id-type="pmid">24013417</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0056">
<label>56</label>
<mixed-citation id="cns13156-cit-0056" publication-type="journal">
<string-name>
<surname>Mao</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Mitochondrial fission facilitates mitophagy in <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source xml:lang="en"/>Autophagy. <year>2013</year>;<volume>9</volume>(<issue>11</issue>):<fpage>1900</fpage>‐<lpage>1901</lpage>.<pub-id pub-id-type="pmid">24025250</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0057">
<label>57</label>
<mixed-citation id="cns13156-cit-0057" publication-type="journal">
<string-name>
<surname>Mendl</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Occhipinti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wild</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dikic</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Reichert</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Mitophagy in yeast is independent of mitochondrial fission and requires the stress response gene WHI2</article-title>. <source xml:lang="en"/>J Cell Sci. <year>2011</year>;<volume>124</volume>(<issue>Pt 8</issue>):<fpage>1339</fpage>‐<lpage>1350</lpage>.<pub-id pub-id-type="pmid">21429936</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0058">
<label>58</label>
<mixed-citation id="cns13156-cit-0058" publication-type="journal">
<string-name>
<surname>Mao</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>The scaffold protein Atg11 recruits fission machinery to drive selective mitochondria degradation by autophagy</article-title>. <source xml:lang="en"/>Dev Cell. <year>2013</year>;<volume>26</volume>(<issue>1</issue>):<fpage>9</fpage>‐<lpage>18</lpage>.<pub-id pub-id-type="pmid">23810512</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0059">
<label>59</label>
<mixed-citation id="cns13156-cit-0059" publication-type="journal">
<string-name>
<surname>Gassmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bettler</surname>
<given-names>B</given-names>
</string-name>. <article-title>Regulation of neuronal GABA(B) receptor functions by subunit composition</article-title>. <source xml:lang="en"/>Nat Rev Neurosci. <year>2012</year>;<volume>13</volume>(<issue>6</issue>):<fpage>380</fpage>‐<lpage>394</lpage>.<pub-id pub-id-type="pmid">22595784</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0060">
<label>60</label>
<mixed-citation id="cns13156-cit-0060" publication-type="journal">
<string-name>
<surname>Schuler</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lüscher</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Blanchet</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Epilepsy, hyperalgesia, impaired memory, and loss of pre‐ and postsynaptic GABA(B) responses in mice lacking GABA(B(1))</article-title>. <source xml:lang="en"/>Neuron. <year>2001</year>;<volume>31</volume>(<issue>1</issue>):<fpage>47</fpage>‐<lpage>58</lpage>.<pub-id pub-id-type="pmid">11498050</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0061">
<label>61</label>
<mixed-citation id="cns13156-cit-0061" publication-type="journal">
<string-name>
<surname>Yoo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jung</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YN</given-names>
</string-name>, et al. <article-title>GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy</article-title>. <source xml:lang="en"/>Ann Neurol. <year>2017</year>;<volume>82</volume>(<issue>3</issue>):<fpage>466</fpage>‐<lpage>478</lpage>.<pub-id pub-id-type="pmid">28856709</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0062">
<label>62</label>
<mixed-citation id="cns13156-cit-0062" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>MTM</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>CS</given-names>
</string-name>, et al. <article-title>Genome‐wide association study of bipolar I disorder in the Han Chinese population</article-title>. <source xml:lang="en"/>Mol Psychiatry. <year>2011</year>;<volume>16</volume>(<issue>5</issue>):<fpage>548</fpage>‐<lpage>556</lpage>.<pub-id pub-id-type="pmid">20386566</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0063">
<label>63</label>
<mixed-citation id="cns13156-cit-0063" publication-type="journal">
<string-name>
<surname>Sibille</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Joeyen‐Waldorf</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>A molecular signature of depression in the amygdala</article-title>. <source xml:lang="en"/>Am J Psychiatry. <year>2009</year>;<volume>166</volume>(<issue>9</issue>):<fpage>1011</fpage>‐<lpage>1024</lpage>.<pub-id pub-id-type="pmid">19605536</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0064">
<label>64</label>
<mixed-citation id="cns13156-cit-0064" publication-type="journal">
<string-name>
<surname>Benes</surname>
<given-names>FM</given-names>
</string-name>. <article-title>Amygdalocortical circuitry in schizophrenia: from circuits to molecules</article-title>. <source xml:lang="en"/>Neuropsychopharmacology. <year>2010</year>;<volume>35</volume>(<issue>1</issue>):<fpage>239</fpage>‐<lpage>257</lpage>.<pub-id pub-id-type="pmid">19727065</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0065">
<label>65</label>
<mixed-citation id="cns13156-cit-0065" publication-type="journal">
<string-name>
<surname>Cathomas</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Stegen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sigrist</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders</article-title>. <source xml:lang="en"/>Transl Psychiatry. <year>2015</year>;<volume>5</volume>:<fpage>e510</fpage>.<pub-id pub-id-type="pmid">25689571</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0066">
<label>66</label>
<mixed-citation id="cns13156-cit-0066" publication-type="journal">
<string-name>
<surname>Chalifoux</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>AG</given-names>
</string-name>. <article-title>GABAB receptor modulation of synaptic function</article-title>. <source xml:lang="en"/>Curr Opin Neurobiol. <year>2011</year>;<volume>21</volume>(<issue>2</issue>):<fpage>339</fpage>‐<lpage>344</lpage>.<pub-id pub-id-type="pmid">21376567</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0067">
<label>67</label>
<mixed-citation id="cns13156-cit-0067" publication-type="journal">
<string-name>
<surname>Adelfinger</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Turecek</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ivankova</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>GABAB receptor phosphorylation regulates KCTD12‐induced K(+) current desensitization</article-title>. <source xml:lang="en"/>Biochem Pharmacol. <year>2014</year>;<volume>91</volume>(<issue>3</issue>):<fpage>369</fpage>‐<lpage>379</lpage>.<pub-id pub-id-type="pmid">25065880</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0068">
<label>68</label>
<mixed-citation id="cns13156-cit-0068" publication-type="journal">
<string-name>
<surname>Michaelson</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gujral</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Whole‐genome sequencing in autism identifies hot spots for de novo germline mutation</article-title>. <source xml:lang="en"/>Cell. <year>2012</year>;<volume>151</volume>(<issue>7</issue>):<fpage>1431</fpage>‐<lpage>1442</lpage>.<pub-id pub-id-type="pmid">23260136</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0069">
<label>69</label>
<mixed-citation id="cns13156-cit-0069" publication-type="journal">
<string-name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Korn</surname>
<given-names>JM</given-names>
</string-name>, et al. <article-title>Association between microdeletion and microduplication at 16p11.2 and autism</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2008</year>;<volume>358</volume>(<issue>7</issue>):<fpage>667</fpage>‐<lpage>675</lpage>.<pub-id pub-id-type="pmid">18184952</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0070">
<label>70</label>
<mixed-citation id="cns13156-cit-0070" publication-type="journal">
<string-name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Makarov</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kirov</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Microduplications of 16p11.2 are associated with schizophrenia</article-title>. <source xml:lang="en"/>Nat Genet. <year>2009</year>;<volume>41</volume>(<issue>11</issue>):<fpage>1223</fpage>‐<lpage>1227</lpage>.<pub-id pub-id-type="pmid">19855392</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0071">
<label>71</label>
<mixed-citation id="cns13156-cit-0071" publication-type="journal">
<string-name>
<surname>Ceol</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Houvras</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jane‐Valbuena</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset</article-title>. <source xml:lang="en"/>Nature. <year>2011</year>;<volume>471</volume>(<issue>7339</issue>):<fpage>513</fpage>‐<lpage>517</lpage>.<pub-id pub-id-type="pmid">21430779</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0072">
<label>72</label>
<mixed-citation id="cns13156-cit-0072" publication-type="journal">
<string-name>
<surname>Walters</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Jacquemont</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Valsesia</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>A new highly penetrant form of obesity due to deletions on chromosome 16p11.2</article-title>. <source xml:lang="en"/>Nature. <year>2010</year>;<volume>463</volume>(<issue>7281</issue>):<fpage>671</fpage>‐<lpage>675</lpage>.<pub-id pub-id-type="pmid">20130649</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0073">
<label>73</label>
<mixed-citation id="cns13156-cit-0073" publication-type="journal">
<string-name>
<surname>Kumar</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>KaraMohamed</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sudi</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Recurrent 16p11.2 microdeletions in autism</article-title>. <source xml:lang="en"/>Hum Mol Genet. <year>2008</year>;<volume>17</volume>(<issue>4</issue>):<fpage>628</fpage>‐<lpage>638</lpage>.<pub-id pub-id-type="pmid">18156158</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0074">
<label>74</label>
<mixed-citation id="cns13156-cit-0074" publication-type="journal">
<string-name>
<surname>Loviglio</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Arbogast</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jønch</surname>
<given-names>AE</given-names>
</string-name>, et al. <article-title>The immune signaling adaptor LAT contributes to the neuroanatomical phenotype of 16p11.2 BP2‐BP3 CNVs</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>2017</year>;<volume>101</volume>(<issue>4</issue>):<fpage>564</fpage>‐<lpage>577</lpage>.<pub-id pub-id-type="pmid">28965845</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0075">
<label>75</label>
<mixed-citation id="cns13156-cit-0075" publication-type="journal">
<string-name>
<surname>Arbogast</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Razaz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ellegood</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Kctd13‐deficient mice display short‐term memory impairment and sex‐dependent genetic interactions</article-title>. <source xml:lang="en"/>Hum Mol Genet. <year>2019</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1474</fpage>–<lpage>1486</lpage>.<pub-id pub-id-type="pmid">30590535</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0076">
<label>76</label>
<mixed-citation id="cns13156-cit-0076" publication-type="journal">
<string-name>
<surname>Gladwyn‐Ng</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ngo</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Bacurd1/Kctd13 and Bacurd2/Tnfaip1 are interacting partners to Rnd proteins which influence the long‐term positioning and dendritic maturation of cerebral cortical neurons</article-title>. <source xml:lang="en"/>Neural Dev. <year>2016</year>;<volume>11</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">26969432</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0077">
<label>77</label>
<mixed-citation id="cns13156-cit-0077" publication-type="journal">
<string-name>
<surname>Albanese</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bressman</surname>
<given-names>SB</given-names>
</string-name>, et al. <article-title>Phenomenology and classification of dystonia: a consensus update</article-title>. <source xml:lang="en"/>Mov Disord. <year>2013</year>;<volume>28</volume>(<issue>7</issue>):<fpage>863</fpage>‐<lpage>873</lpage>.<pub-id pub-id-type="pmid">23649720</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0078">
<label>78</label>
<mixed-citation id="cns13156-cit-0078" publication-type="journal">
<string-name>
<surname>Zimprich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Grabowski</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Asmus</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Mutations in the gene encoding epsilon‐sarcoglycan cause myoclonus‐dystonia syndrome</article-title>. <source xml:lang="en"/>Nat Genet. <year>2001</year>;<volume>29</volume>(<issue>1</issue>):<fpage>66</fpage>‐<lpage>69</lpage>.<pub-id pub-id-type="pmid">11528394</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0079">
<label>79</label>
<mixed-citation id="cns13156-cit-0079" publication-type="journal">
<string-name>
<surname>Mencacci</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Rubio‐Agusti</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Zdebik</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>A missense mutation in KCTD17 causes autosomal dominant myoclonus‐dystonia</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>2015</year>;<volume>96</volume>(<issue>6</issue>):<fpage>938</fpage>‐<lpage>947</lpage>.<pub-id pub-id-type="pmid">25983243</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0080">
<label>80</label>
<mixed-citation id="cns13156-cit-0080" publication-type="journal">
<string-name>
<surname>Mencacci</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Bruggemann</surname>
<given-names>N</given-names>
</string-name>. <article-title>KCTD17 is a confirmed new gene for dystonia, but is it responsible for SGCE‐negative myoclonus‐dystonia?</article-title>
<source xml:lang="en"/>Parkinsonism Relat Disord. <year>2019</year>;<volume>61</volume>:<fpage>887</fpage>‐<lpage>3</lpage>.</mixed-citation>
</ref>
<ref id="cns13156-bib-0081">
<label>81</label>
<mixed-citation id="cns13156-cit-0081" publication-type="journal">
<string-name>
<surname>Graziola</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Stregapede</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Travaglini</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>A novel KCTD17 mutation is associated with childhood early‐onset hyperkinetic movement disorder</article-title>. <source xml:lang="en"/>Parkinsonism Relat Disord. <year>2019</year>;<volume>61</volume>:<fpage>4</fpage>‐<lpage>6</lpage>.<pub-id pub-id-type="pmid">30579817</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0082">
<label>82</label>
<mixed-citation id="cns13156-cit-0082" publication-type="journal">
<string-name>
<surname>Marcé‐Grau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Correa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vanegas</surname>
<given-names>MI</given-names>
</string-name>, et al. <article-title>Childhood onset progressive myoclonic dystonia due to a de novo KCTD17 splicing mutation</article-title>. <source xml:lang="en"/>Parkinsonism Relat Disord. <year>2019</year>;<volume>61</volume>:<fpage>7</fpage>‐<lpage>9</lpage>.<pub-id pub-id-type="pmid">30642807</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0083">
<label>83</label>
<mixed-citation id="cns13156-cit-0083" publication-type="journal">
<string-name>
<surname>Domingo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Erro</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lohmann</surname>
<given-names>K</given-names>
</string-name>. <article-title>Novel dystonia genes: Clues on disease mechanisms and the complexities of high‐throughput sequencing</article-title>. <source xml:lang="en"/>Mov Disord. <year>2016</year>;<volume>31</volume>(<issue>4</issue>):<fpage>471</fpage>‐<lpage>477</lpage>.<pub-id pub-id-type="pmid">26991507</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0084">
<label>84</label>
<mixed-citation id="cns13156-cit-0084" publication-type="journal">
<string-name>
<surname>Metin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pedraza</surname>
<given-names>M</given-names>
</string-name>. <article-title>Cilia: traffic directors along the road of cortical development</article-title>. <source xml:lang="en"/>Neuroscientist. <year>2014</year>;<volume>20</volume>(<issue>5</issue>):<fpage>468</fpage>‐<lpage>482</lpage>.<pub-id pub-id-type="pmid">25037053</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0085">
<label>85</label>
<mixed-citation id="cns13156-cit-0085" publication-type="journal">
<string-name>
<surname>Pfeiffenberger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Allada</surname>
<given-names>R</given-names>
</string-name>. <article-title>Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila</article-title>. <source xml:lang="en"/>PLoS Genet. <year>2012</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e1003003</fpage>.<pub-id pub-id-type="pmid">23055946</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0086">
<label>86</label>
<mixed-citation id="cns13156-cit-0086" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Kellner</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Hatch</surname>
<given-names>HAM</given-names>
</string-name>, et al. <article-title>Conserved properties of Drosophila Insomniac link sleep regulation and synaptic function</article-title>. <source xml:lang="en"/>PLoS Genet. <year>2017</year>;<volume>13</volume>(<issue>5</issue>):<fpage>e1006815</fpage>.<pub-id pub-id-type="pmid">28558011</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0087">
<label>87</label>
<mixed-citation id="cns13156-cit-0087" publication-type="journal">
<string-name>
<surname>Karimi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Perlmutter</surname>
<given-names>JS</given-names>
</string-name>. <article-title>The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging</article-title>. <source xml:lang="en"/>Tremor Other Hyperkinet Mov (N Y). <year>2015</year>;<volume>5</volume>:<fpage>280</fpage>.<pub-id pub-id-type="pmid">25713747</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0088">
<label>88</label>
<mixed-citation id="cns13156-cit-0088" publication-type="journal">
<string-name>
<surname>Alazami</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shamseldin</surname>
<given-names>HE</given-names>
</string-name>, et al. <article-title>Accelerating novel candidate gene discovery in neurogenetic disorders via whole‐exome sequencing of prescreened multiplex consanguineous families</article-title>. <source xml:lang="en"/>Cell Rep. <year>2015</year>;<volume>10</volume>(<issue>2</issue>):<fpage>148</fpage>‐<lpage>161</lpage>.<pub-id pub-id-type="pmid">25558065</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0089">
<label>89</label>
<mixed-citation id="cns13156-cit-0089" publication-type="journal">
<string-name>
<surname>Trujillano</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bertoli‐Avella</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kumar Kandaswamy</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Clinical exome sequencing: results from 2819 samples reflecting 1000 families</article-title>. <source xml:lang="en"/>Eur J Hum Genet. <year>2017</year>;<volume>25</volume>(<issue>2</issue>):<fpage>176</fpage>‐<lpage>182</lpage>.<pub-id pub-id-type="pmid">27848944</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0090">
<label>90</label>
<mixed-citation id="cns13156-cit-0090" publication-type="journal">
<string-name>
<surname>Faqeih</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Almannai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Saleh</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>AlWadei</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Samman</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Alkuraya</surname>
<given-names>FS</given-names>
</string-name>. <article-title>Phenotypic characterization of KCTD3‐related developmental epileptic encephalopathy</article-title>. <source xml:lang="en"/>Clin Genet. <year>2018</year>;<volume>93</volume>(<issue>5</issue>):<fpage>1081</fpage>‐<lpage>1086</lpage>.<pub-id pub-id-type="pmid">29406573</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0091">
<label>91</label>
<mixed-citation id="cns13156-cit-0091" publication-type="journal">
<string-name>
<surname>Cao‐Ehlker</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zong</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hammelmann</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Up‐regulation of hyperpolarization‐activated cyclic nucleotide‐gated channel 3 (HCN3) by specific interaction with K+ channel tetramerization domain‐containing protein 3 (KCTD3)</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2013</year>;<volume>288</volume>(<issue>11</issue>):<fpage>7580</fpage>‐<lpage>7589</lpage>.<pub-id pub-id-type="pmid">23382386</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0092">
<label>92</label>
<mixed-citation id="cns13156-cit-0092" publication-type="journal">
<string-name>
<surname>Biel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wahl‐Schott</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Michalakis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zong</surname>
<given-names>X</given-names>
</string-name>. <article-title>Hyperpolarization‐activated cation channels: from genes to function</article-title>. <source xml:lang="en"/>Physiol Rev. <year>2009</year>;<volume>89</volume>(<issue>3</issue>):<fpage>847</fpage>‐<lpage>885</lpage>.<pub-id pub-id-type="pmid">19584315</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0093">
<label>93</label>
<mixed-citation id="cns13156-cit-0093" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lujan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kadurin</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Presynaptic HCN1 channels regulate Cav3.2 activity and neurotransmission at select cortical synapses</article-title>. <source xml:lang="en"/>Nat Neurosci. <year>2011</year>;<volume>14</volume>(<issue>4</issue>):<fpage>478</fpage>‐<lpage>486</lpage>.<pub-id pub-id-type="pmid">21358644</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0094">
<label>94</label>
<mixed-citation id="cns13156-cit-0094" publication-type="journal">
<string-name>
<surname>Di Marcotullio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ferretti</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>De Smaele</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>2004</year>;<volume>101</volume>(<issue>29</issue>):<fpage>10833</fpage>‐<lpage>10838</lpage>.<pub-id pub-id-type="pmid">15249678</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0095">
<label>95</label>
<mixed-citation id="cns13156-cit-0095" publication-type="journal">
<string-name>
<surname>Scuoppo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Miething</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lindqvist</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>A tumour suppressor network relying on the polyamine‐hypusine axis</article-title>. <source xml:lang="en"/>Nature. <year>2012</year>;<volume>487</volume>(<issue>7406</issue>):<fpage>244</fpage>‐<lpage>248</lpage>.<pub-id pub-id-type="pmid">22722845</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0096">
<label>96</label>
<mixed-citation id="cns13156-cit-0096" publication-type="journal">
<string-name>
<surname>Correale</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pirone</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Di Marcotullio</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Molecular organization of the cullin E3 ligase adaptor KCTD11</article-title>. <source xml:lang="en"/>Biochimie. <year>2011</year>;<volume>93</volume>(<issue>4</issue>):<fpage>715</fpage>‐<lpage>724</lpage>.<pub-id pub-id-type="pmid">21237243</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0097">
<label>97</label>
<mixed-citation id="cns13156-cit-0097" publication-type="journal">
<string-name>
<surname>Willer</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Speliotes</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Loos</surname>
<given-names>RJ</given-names>
</string-name>, et al. <article-title>Six new loci associated with body mass index highlight a neuronal influence on body weight regulation</article-title>. <source xml:lang="en"/>Nat Genet. <year>2009</year>;<volume>41</volume>(<issue>1</issue>):<fpage>25</fpage>‐<lpage>34</lpage>.<pub-id pub-id-type="pmid">19079261</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0098">
<label>98</label>
<mixed-citation id="cns13156-cit-0098" publication-type="journal">
<string-name>
<surname>Baranski</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Kraja</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Fink</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>A high throughput, functional screen of human Body Mass Index GWAS loci using tissue‐specific RNAi <italic>Drosophila melanogaster</italic> crosses</article-title>. <source xml:lang="en"/>PLoS Genet. <year>2018</year>;<volume>14</volume>(<issue>4</issue>):<fpage>e1007222</fpage>.<pub-id pub-id-type="pmid">29608557</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0099">
<label>99</label>
<mixed-citation id="cns13156-cit-0099" publication-type="journal">
<string-name>
<surname>Dutta</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dawid</surname>
<given-names>IB</given-names>
</string-name>. <article-title>Kctd15 inhibits neural crest formation by attenuating Wnt/beta‐catenin signaling output</article-title>. <source xml:lang="en"/>Development. <year>2010</year>;<volume>137</volume>(<issue>18</issue>):<fpage>3013</fpage>‐<lpage>3018</lpage>.<pub-id pub-id-type="pmid">20685732</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0100">
<label>100</label>
<mixed-citation id="cns13156-cit-0100" publication-type="journal">
<string-name>
<surname>Zarelli</surname>
<given-names>VE</given-names>
</string-name>, <string-name>
<surname>Dawid</surname>
<given-names>IB</given-names>
</string-name>. <article-title>The BTB‐containing protein Kctd15 is SUMOylated in vivo</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2013</year>;<volume>8</volume>(<issue>9</issue>):<fpage>e75016</fpage>.<pub-id pub-id-type="pmid">24086424</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0101">
<label>101</label>
<mixed-citation id="cns13156-cit-0101" publication-type="journal">
<string-name>
<surname>Billon</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Monteiro</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Dani</surname>
<given-names>C</given-names>
</string-name>. <article-title>Developmental origin of adipocytes: new insights into a pending question</article-title>. <source xml:lang="en"/>Biol Cell. <year>2008</year>;<volume>100</volume>(<issue>10</issue>):<fpage>563</fpage>‐<lpage>575</lpage>.<pub-id pub-id-type="pmid">18793119</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0102">
<label>102</label>
<mixed-citation id="cns13156-cit-0102" publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>QQ</given-names>
</string-name>, <string-name>
<surname>McLenithan</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Derepression of the C/EBPalpha gene during adipogenesis: identification of AP‐2alpha as a repressor</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>1998</year>;<volume>95</volume>(<issue>7</issue>):<fpage>3467</fpage>‐<lpage>3471</lpage>.<pub-id pub-id-type="pmid">9520389</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0103">
<label>103</label>
<mixed-citation id="cns13156-cit-0103" publication-type="journal">
<string-name>
<surname>Meng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Morino</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Transcription factor AP‐2beta: a negative regulator of IRS‐1 gene expression</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun. <year>2010</year>;<volume>392</volume>(<issue>4</issue>):<fpage>526</fpage>‐<lpage>532</lpage>.<pub-id pub-id-type="pmid">20097161</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0104">
<label>104</label>
<mixed-citation id="cns13156-cit-0104" publication-type="journal">
<string-name>
<surname>Novy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Catarino</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>Chinthapalli</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Another cause of vaccine encephalopathy: a case of Angelman syndrome</article-title>. <source xml:lang="en"/>Eur J Med Genet. <year>2012</year>;<volume>55</volume>(<issue>5</issue>):<fpage>338</fpage>‐<lpage>341</lpage>.<pub-id pub-id-type="pmid">22342448</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0105">
<label>105</label>
<mixed-citation id="cns13156-cit-0105" publication-type="journal">
<string-name>
<surname>Zamponi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Passamonti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Petrelli</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Vaccination and occurrence of seizures in SCN1A mutation‐positive patients: a multicenter Italian study</article-title>. <source xml:lang="en"/>Pediatr Neurol. <year>2014</year>;<volume>50</volume>(<issue>3</issue>):<fpage>228</fpage>‐<lpage>232</lpage>.<pub-id pub-id-type="pmid">24405698</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0106">
<label>106</label>
<mixed-citation id="cns13156-cit-0106" publication-type="journal">
<string-name>
<surname>Inaba</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kasahara</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Ndel1 suppresses ciliogenesis in proliferating cells by regulating the trichoplein‐Aurora A pathway</article-title>. <source xml:lang="en"/>J Cell Biol. <year>2016</year>;<volume>212</volume>(<issue>4</issue>):<fpage>409</fpage>‐<lpage>423</lpage>.<pub-id pub-id-type="pmid">26880200</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0107">
<label>107</label>
<mixed-citation id="cns13156-cit-0107" publication-type="journal">
<string-name>
<surname>Smaldone</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pirone</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pedone</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Marlovits</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Vitagliano</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ciccarelli</surname>
<given-names>L</given-names>
</string-name>. <article-title>The BTB domains of the potassium channel tetramerization domain proteins prevalently assume pentameric states</article-title>. <source xml:lang="en"/>FEBS Lett. <year>2016</year>;<volume>590</volume>(<issue>11</issue>):<fpage>1663</fpage>‐<lpage>1671</lpage>.<pub-id pub-id-type="pmid">27152988</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0108">
<label>108</label>
<mixed-citation id="cns13156-cit-0108" publication-type="journal">
<string-name>
<surname>Vlasenko</surname>
<given-names>DO</given-names>
</string-name>, <string-name>
<surname>Novosylna</surname>
<given-names>OV</given-names>
</string-name>, <string-name>
<surname>Negrutskii</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>El'skaya</surname>
<given-names>AV</given-names>
</string-name>. <article-title>Truncation of the A, A(*), A' helices segment impairs the actin bundling activity of mammalian eEF1A1</article-title>. <source xml:lang="en"/>FEBS Lett. <year>2015</year>;<volume>589</volume>(<issue>11</issue>):<fpage>1187</fpage>‐<lpage>1193</lpage>.<pub-id pub-id-type="pmid">25862498</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0109">
<label>109</label>
<mixed-citation id="cns13156-cit-0109" publication-type="journal">
<string-name>
<surname>Pirone</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Correale</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>de Paola</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Design, synthesis and characterization of a peptide able to bind proteins of the KCTD family: implications for KCTD‐cullin 3 recognition</article-title>. <source xml:lang="en"/>J Pept Sci. <year>2011</year>;<volume>17</volume>(<issue>5</issue>):<fpage>373</fpage>‐<lpage>376</lpage>.<pub-id pub-id-type="pmid">21438081</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0110">
<label>110</label>
<mixed-citation id="cns13156-cit-0110" publication-type="journal">
<string-name>
<surname>Traylor</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Adib‐Samii</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Harold</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Shared genetic contribution to ischaemic stroke and Alzheimer's Disease</article-title>. <source xml:lang="en"/>Ann Neurol. <year>2016</year>;<volume>79</volume>(<issue>5</issue>):<fpage>739</fpage>‐<lpage>747</lpage>.<pub-id pub-id-type="pmid">26913989</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0111">
<label>111</label>
<mixed-citation id="cns13156-cit-0111" publication-type="journal">
<string-name>
<surname>Boada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Antúnez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ramírez‐Lorca</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>ATP5H/KCTD2 locus is associated with Alzheimer's disease risk</article-title>. <source xml:lang="en"/>Mol Psychiatry. <year>2014</year>;<volume>19</volume>(<issue>6</issue>):<fpage>682</fpage>‐<lpage>687</lpage>.<pub-id pub-id-type="pmid">23857120</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0112">
<label>112</label>
<mixed-citation id="cns13156-cit-0112" publication-type="journal">
<string-name>
<surname>Feng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Geng</surname>
<given-names>JG</given-names>
</string-name>. <article-title>SH3KBP1‐binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c‐Cbl‐CIN85 complex</article-title>. <source xml:lang="en"/>Cell Biochem Funct. <year>2011</year>;<volume>29</volume>(<issue>7</issue>):<fpage>589</fpage>‐<lpage>596</lpage>.<pub-id pub-id-type="pmid">21830225</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0113">
<label>113</label>
<mixed-citation id="cns13156-cit-0113" publication-type="journal">
<string-name>
<surname>Borinstein</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Hyatt</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Sykes</surname>
<given-names>VW</given-names>
</string-name>, et al. <article-title>SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins</article-title>. <source xml:lang="en"/>Cell Signal. <year>2000</year>;<volume>12</volume>(<issue>11–12</issue>):<fpage>769</fpage>‐<lpage>779</lpage>.<pub-id pub-id-type="pmid">11152963</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0114">
<label>114</label>
<mixed-citation id="cns13156-cit-0114" publication-type="journal">
<collab collab-type="authors">Cancer Genome Atlas Research N</collab>
, <collab collab-type="authors">Albert Einstein College of M</collab>
, <collab collab-type="authors">Analytical Biological S</collab>
, et al. <article-title>Integrated genomic and molecular characterization of cervical cancer</article-title>. <source xml:lang="en"/>Nature. <year>2017</year>;<volume>543</volume>(<issue>7645</issue>):<fpage>378</fpage>‐<lpage>384</lpage>.<pub-id pub-id-type="pmid">28112728</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0115">
<label>115</label>
<mixed-citation id="cns13156-cit-0115" publication-type="journal">
<string-name>
<surname>Greif</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Eck</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Konstandin</surname>
<given-names>NP</given-names>
</string-name>, et al. <article-title>Identification of recurring tumor‐specific somatic mutations in acute myeloid leukemia by transcriptome sequencing</article-title>. <source xml:lang="en"/>Leukemia. <year>2011</year>;<volume>25</volume>(<issue>5</issue>):<fpage>821</fpage>‐<lpage>827</lpage>.<pub-id pub-id-type="pmid">21339757</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0116">
<label>116</label>
<mixed-citation id="cns13156-cit-0116" publication-type="journal">
<string-name>
<surname>Darmanis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Drobin</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Identification of candidate serum proteins for classifying well‐differentiated small intestinal neuroendocrine tumors</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2013</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e81712</fpage>.<pub-id pub-id-type="pmid">24282616</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0117">
<label>117</label>
<mixed-citation id="cns13156-cit-0117" publication-type="journal">
<string-name>
<surname>Nagai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mukoyama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kagiwada</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Goshima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>K</given-names>
</string-name>. <article-title>Cullin‐3‐KCTD10‐mediated CEP97 degradation promotes primary cilium formation</article-title>. <source xml:lang="en"/>J Cell Sci. <year>2018</year>;<volume>131</volume>(<issue>24</issue>):<fpage>jcs219527</fpage>.<pub-id pub-id-type="pmid">30404837</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0118">
<label>118</label>
<mixed-citation id="cns13156-cit-0118" publication-type="journal">
<string-name>
<surname>Hu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>TNFAIP1 interacts with KCTD10 to promote the degradation of KCTD10 proteins and inhibit the transcriptional activities of NF‐kappaB and AP‐1</article-title>. <source xml:lang="en"/>Mol Biol Rep. <year>2012</year>;<volume>39</volume>(<issue>11</issue>):<fpage>9911</fpage>‐<lpage>9919</lpage>.<pub-id pub-id-type="pmid">22810651</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0119">
<label>119</label>
<mixed-citation id="cns13156-cit-0119" publication-type="journal">
<string-name>
<surname>Kubota</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tsuda</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2013</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e73896</fpage>.<pub-id pub-id-type="pmid">23977394</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0120">
<label>120</label>
<mixed-citation id="cns13156-cit-0120" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</string-name>, et al. <article-title>RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells</article-title>. <source xml:lang="en"/>Int J Cancer. <year>2009</year>;<volume>125</volume>(<issue>11</issue>):<fpage>2520</fpage>‐<lpage>2527</lpage>.<pub-id pub-id-type="pmid">19637314</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0121">
<label>121</label>
<mixed-citation id="cns13156-cit-0121" publication-type="journal">
<string-name>
<surname>Cui</surname>
<given-names>RI</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>H‐L</given-names>
</string-name>, et al. <article-title>MicroRNA‐224 promotes tumor progression in nonsmall cell lung cancer</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>2015</year>;<volume>112</volume>(<issue>31</issue>):<fpage>E4288</fpage>‐<lpage>4297</lpage>.<pub-id pub-id-type="pmid">26187928</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0122">
<label>122</label>
<mixed-citation id="cns13156-cit-0122" publication-type="journal">
<string-name>
<surname>Grinchuk</surname>
<given-names>OV</given-names>
</string-name>, <string-name>
<surname>Motakis</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kuznetsov</surname>
<given-names>VA</given-names>
</string-name>. <article-title>Complex sense‐antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural‐functional gene module involved in breast cancer progression</article-title>. <source xml:lang="en"/>BMC Genom. <year>2010</year>;<volume>11</volume>(<issue>Suppl 1</issue>):<fpage>S9</fpage>.</mixed-citation>
</ref>
<ref id="cns13156-bib-0123">
<label>123</label>
<mixed-citation id="cns13156-cit-0123" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>XH</given-names>
</string-name>. <article-title>Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor‐kappaB pathway</article-title>. <source xml:lang="en"/>Oncol Rep. <year>2014</year>;<volume>32</volume>(<issue>3</issue>):<fpage>1149</fpage>‐<lpage>1155</lpage>.<pub-id pub-id-type="pmid">24969828</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0124">
<label>124</label>
<mixed-citation id="cns13156-cit-0124" publication-type="journal">
<string-name>
<surname>Degenhardt</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Heinemann</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Strohmaier</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Identification of rare variants in KCTD13 at the schizophrenia risk locus 16p11.2</article-title>. <source xml:lang="en"/>Psychiatr Genet. <year>2016</year>;<volume>26</volume>(<issue>6</issue>):<fpage>293</fpage>‐<lpage>296</lpage>.<pub-id pub-id-type="pmid">27668412</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0125">
<label>125</label>
<mixed-citation id="cns13156-cit-0125" publication-type="journal">
<string-name>
<surname>Blumkin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kivity</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lev</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus‐myoclonus ataxia‐like syndrome</article-title>. <source xml:lang="en"/>J Neurol. <year>2012</year>;<volume>259</volume>:<fpage>2590</fpage>‐<lpage>2598</lpage>.<pub-id pub-id-type="pmid">22638565</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0126">
<label>126</label>
<mixed-citation id="cns13156-cit-0126" publication-type="journal">
<string-name>
<surname>Heride</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rigden</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Bertsoulaki</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>The centrosomal deubiquitylase USP21 regulates Gli1 transcriptional activity and stability</article-title>. <source xml:lang="en"/>J Cell Sci. <year>2016</year>;<volume>129</volume>(<issue>21</issue>):<fpage>4001</fpage>‐<lpage>4013</lpage>.<pub-id pub-id-type="pmid">27621083</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0127">
<label>127</label>
<mixed-citation id="cns13156-cit-0127" publication-type="journal">
<string-name>
<surname>Lange</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Teh</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>. <article-title>Obscurin and KCTD6 regulate cullin‐dependent small ankyrin‐1 (sAnk1.5) protein turnover</article-title>. <source xml:lang="en"/>Mol Biol Cell. <year>2012</year>;<volume>23</volume>(<issue>13</issue>):<fpage>2490</fpage>‐<lpage>2504</lpage>.<pub-id pub-id-type="pmid">22573887</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0128">
<label>128</label>
<mixed-citation id="cns13156-cit-0128" publication-type="journal">
<string-name>
<surname>Al‐Mubarak</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Abouelhoda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Omar</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families</article-title>. <source xml:lang="en"/>Sci Rep. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>5679</fpage>.<pub-id pub-id-type="pmid">28720891</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0129">
<label>129</label>
<mixed-citation id="cns13156-cit-0129" publication-type="journal">
<string-name>
<surname>Zazzeroni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nicosia</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tessitore</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma</article-title>. <source xml:lang="en"/>Biomed Res Int. <year>2014</year>;<volume>2014</volume>:<fpage>380398</fpage>.<pub-id pub-id-type="pmid">25045667</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0130">
<label>130</label>
<mixed-citation id="cns13156-cit-0130" publication-type="journal">
<string-name>
<surname>Tong</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling</article-title>. <source xml:lang="en"/>Oncotarget. <year>2017</year>;<volume>8</volume>(<issue>23</issue>):<fpage>37717</fpage>‐<lpage>37729</lpage>.<pub-id pub-id-type="pmid">28465479</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0131">
<label>131</label>
<mixed-citation id="cns13156-cit-0131" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>KCTD1 suppresses canonical Wnt signaling pathway by enhancing beta‐catenin degradation</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2014</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e94343</fpage>.<pub-id pub-id-type="pmid">24736394</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0132">
<label>132</label>
<mixed-citation id="cns13156-cit-0132" publication-type="journal">
<string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rathkolb</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sabrautzki</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Standardized, systemic phenotypic analysis reveals kidney dysfunction as main alteration of Kctd1 (I27N) mutant mice</article-title>. <source xml:lang="en"/>J Biomed Sci. <year>2017</year>;<volume>24</volume>(<issue>1</issue>):<fpage>57</fpage>.<pub-id pub-id-type="pmid">28818080</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0133">
<label>133</label>
<mixed-citation id="cns13156-cit-0133" publication-type="journal">
<string-name>
<surname>Marneros</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Beck</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>EH</given-names>
</string-name>, et al. <article-title>Mutations in KCTD1 cause scalp‐ear‐nipple syndrome</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>2013</year>;<volume>92</volume>(<issue>4</issue>):<fpage>621</fpage>‐<lpage>626</lpage>.<pub-id pub-id-type="pmid">23541344</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0134">
<label>134</label>
<mixed-citation id="cns13156-cit-0134" publication-type="journal">
<string-name>
<surname>Zhong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>WW</given-names>
</string-name>, et al. <article-title>KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A‐dependent G2/M transition</article-title>. <source xml:lang="en"/>Oncogene. <year>2017</year>;<volume>36</volume>(<issue>44</issue>):<fpage>6177</fpage>‐<lpage>6189</lpage>.<pub-id pub-id-type="pmid">28869606</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0135">
<label>135</label>
<mixed-citation id="cns13156-cit-0135" publication-type="journal">
<string-name>
<surname>Ivankova</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Turecek</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fritzius</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Up‐regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain‐containing protein 12 (KCTD12)</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2013</year>;<volume>288</volume>(<issue>34</issue>):<fpage>24848</fpage>‐<lpage>24856</lpage>.<pub-id pub-id-type="pmid">23843457</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0136">
<label>136</label>
<mixed-citation id="cns13156-cit-0136" publication-type="journal">
<string-name>
<surname>Fritzius</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Turecek</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Seddik</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>KCTD hetero‐oligomers confer unique kinetic properties on hippocampal GABAB receptor‐induced K+ currents</article-title>. <source xml:lang="en"/>J Neurosci. <year>2017</year>;<volume>37</volume>(<issue>5</issue>):<fpage>1162</fpage>‐<lpage>1175</lpage>.<pub-id pub-id-type="pmid">28003345</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0137">
<label>137</label>
<mixed-citation id="cns13156-cit-0137" publication-type="journal">
<string-name>
<surname>Abbaszadegan</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Taghehchian</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Aarabi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moghbeli</surname>
<given-names>M</given-names>
</string-name>. <article-title>Contribution of KCTD12 to esophageal squamous cell carcinoma</article-title>. <source xml:lang="en"/>BMC Cancer. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>853</fpage>.<pub-id pub-id-type="pmid">30157793</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0138">
<label>138</label>
<mixed-citation id="cns13156-cit-0138" publication-type="journal">
<string-name>
<surname>Hasegawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Asanuma</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ogino</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Use of potassium channel tetramerization domain‐containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor</article-title>. <source xml:lang="en"/>Hum Pathol. <year>2013</year>;<volume>44</volume>(<issue>7</issue>):<fpage>1271</fpage>‐<lpage>1277</lpage>.<pub-id pub-id-type="pmid">23290008</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0139">
<label>139</label>
<mixed-citation id="cns13156-cit-0139" publication-type="journal">
<string-name>
<surname>Usman</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mathew</surname>
<given-names>MK</given-names>
</string-name>. <article-title>Potassium channel regulator KCNRG regulates surface expression of Shaker‐type potassium channels</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun. <year>2010</year>;<volume>391</volume>(<issue>3</issue>):<fpage>1301</fpage>‐<lpage>1305</lpage>.<pub-id pub-id-type="pmid">19968958</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0140">
<label>140</label>
<mixed-citation id="cns13156-cit-0140" publication-type="journal">
<string-name>
<surname>Ivanov</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Tyazhelova</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>Lemonnier</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3</article-title>. <source xml:lang="en"/>FEBS Lett. <year>2003</year>;<volume>539</volume>(<issue>1–3</issue>):<fpage>156</fpage>‐<lpage>160</lpage>.<pub-id pub-id-type="pmid">12650944</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0141">
<label>141</label>
<mixed-citation id="cns13156-cit-0141" publication-type="journal">
<string-name>
<surname>Tyybakinoja</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vilpo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Knuutila</surname>
<given-names>S</given-names>
</string-name>. <article-title>High‐resolution oligonucleotide array‐CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia</article-title>. <source xml:lang="en"/>Cytogenet Genome Res. <year>2007</year>;<volume>118</volume>(<issue>1</issue>):<fpage>8</fpage>‐<lpage>12</lpage>.<pub-id pub-id-type="pmid">17901694</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0142">
<label>142</label>
<mixed-citation id="cns13156-cit-0142" publication-type="journal">
<string-name>
<surname>Birerdinc</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nohelty</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Marakhonov</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Pro‐apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region</article-title>. <source xml:lang="en"/>Tumour Biol. <year>2010</year>;<volume>31</volume>(<issue>1</issue>):<fpage>33</fpage>‐<lpage>45</lpage>.<pub-id pub-id-type="pmid">20237900</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0143">
<label>143</label>
<mixed-citation id="cns13156-cit-0143" publication-type="journal">
<string-name>
<surname>Usui</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Interstitial duplication of 2q32.1‐q33.3 in a patient with epilepsy, developmental delay, and autistic behavior</article-title>. <source xml:lang="en"/>Am J Med Genet A. <year>2013</year>;<volume>161A</volume>(<issue>5</issue>):<fpage>1078</fpage>‐<lpage>1084</lpage>.<pub-id pub-id-type="pmid">23463730</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0144">
<label>144</label>
<mixed-citation id="cns13156-cit-0144" publication-type="journal">
<string-name>
<surname>Pichler</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Schwienbacher</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zanon</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Fine‐mapping of restless legs locus 4 (RLS4) identifies a haplotype over the SPATS2L and KCTD18 genes</article-title>. <source xml:lang="en"/>J Mol Neurosci. <year>2013</year>;<volume>49</volume>(<issue>3</issue>):<fpage>600</fpage>‐<lpage>605</lpage>.<pub-id pub-id-type="pmid">23054586</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0145">
<label>145</label>
<mixed-citation id="cns13156-cit-0145" publication-type="journal">
<string-name>
<surname>Nawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matsuoka</surname>
<given-names>M</given-names>
</string-name>. <article-title>KCTD20, a relative of BTBD10, is a positive regulator of Akt</article-title>. <source xml:lang="en"/>BMC Biochem. <year>2013</year>;<volume>14</volume>:<fpage>27</fpage>.<pub-id pub-id-type="pmid">24156551</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0146">
<label>146</label>
<mixed-citation id="cns13156-cit-0146" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Kctd20 promotes the development of non‐small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients</article-title>. <source xml:lang="en"/>Mol Carcinog. <year>2017</year>;<volume>56</volume>(<issue>9</issue>):<fpage>2058</fpage>‐<lpage>2065</lpage>.<pub-id pub-id-type="pmid">28398603</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0147">
<label>147</label>
<mixed-citation id="cns13156-cit-0147" publication-type="journal">
<string-name>
<surname>Rich</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Goodarzi</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>ND</given-names>
</string-name>, et al. <article-title>A genome‐wide association scan for acute insulin response to glucose in Hispanic‐Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS)</article-title>. <source xml:lang="en"/>Diabetologia. <year>2009</year>;<volume>52</volume>(<issue>7</issue>):<fpage>1326</fpage>‐<lpage>1333</lpage>.<pub-id pub-id-type="pmid">19430760</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0148">
<label>148</label>
<mixed-citation id="cns13156-cit-0148" publication-type="journal">
<string-name>
<surname>Nawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kanekura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hashimoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Aiso</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Matsuoka</surname>
<given-names>M</given-names>
</string-name>. <article-title>A novel Akt/PKB‐interacting protein promotes cell adhesion and inhibits familial amyotrophic lateral sclerosis‐linked mutant SOD1‐induced neuronal death via inhibition of PP2A‐mediated dephosphorylation of Akt/PKB</article-title>. <source xml:lang="en"/>Cell Signal. <year>2008</year>;<volume>20</volume>(<issue>3</issue>):<fpage>493</fpage>‐<lpage>505</lpage>.<pub-id pub-id-type="pmid">18160256</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0149">
<label>149</label>
<mixed-citation id="cns13156-cit-0149" publication-type="journal">
<string-name>
<surname>Nawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kage‐Nakadai</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Aiso</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mitani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Matsuoka</surname>
<given-names>M</given-names>
</string-name>. <article-title>Reduced expression of BTBD10, an Akt activator, leads to motor neuron death</article-title>. <source xml:lang="en"/>Cell Death Differ. <year>2012</year>;<volume>19</volume>(<issue>8</issue>):<fpage>1398</fpage>‐<lpage>1407</lpage>.<pub-id pub-id-type="pmid">22388351</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0150">
<label>150</label>
<mixed-citation id="cns13156-cit-0150" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Involvement of GMRP1, a novel mediator of Akt pathway, in brain damage after intracerebral hemorrhage</article-title>. <source xml:lang="en"/>Int J Clin Exp Pathol. <year>2013</year>;<volume>6</volume>(<issue>2</issue>):<fpage>224</fpage>‐<lpage>229</lpage>.<pub-id pub-id-type="pmid">23330007</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0151">
<label>151</label>
<mixed-citation id="cns13156-cit-0151" publication-type="journal">
<string-name>
<surname>Furuta</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Makioka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujita</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Reduced expression of BTBD10 in anterior horn cells with Golgi fragmentation and pTDP‐43‐positive inclusions in patients with sporadic amyotrophic lateral sclerosis</article-title>. <source xml:lang="en"/>Neuropathology. <year>2013</year>;<volume>33</volume>(<issue>4</issue>):<fpage>397</fpage>‐<lpage>404</lpage>.<pub-id pub-id-type="pmid">23320755</pub-id></mixed-citation>
</ref>
<ref id="cns13156-bib-0152">
<label>152</label>
<mixed-citation id="cns13156-cit-0152" publication-type="journal">
<string-name>
<surname>Harata</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nishiuchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kubo</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Colletotrichum orbiculare WHI2, a yeast stress‐response regulator homolog, controls the biotrophic stage of hemibiotrophic infection through TOR signaling</article-title>. <source xml:lang="en"/>Mol Plant Microbe Interact. <year>2016</year>;<volume>29</volume>(<issue>6</issue>):<fpage>468</fpage>‐<lpage>483</lpage>.<pub-id pub-id-type="pmid">27018615</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>